| term overlap_mean setsize_mean score_mean pval_mean overlap_std setsize_std score_std pval_std |
| 2 ltr circle formation 2.0 7.0 10.0 0.0115035556388008 0.0 0.0 0.0 0.0 |
| A tetrasaccharide linker sequence is required for gag synthesis 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abacavir metabolism 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abacavir transmembrane transport 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abacavir transport and metabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abc family proteins mediated transport 0.0 75.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abc transporter disorders 0.0 61.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abc transporters in lipid homeostasis 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aberrant regulation of mitotic exit in cancer due to rb1 defects 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aberrant regulation of mitotic g1 s transition in cancer due to rb1 defects 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abortive elongation of hiv 1 transcript in the absence of tat 1.0 23.0 1.819098240469208 0.4340702418800846 0.0 0.0 0.0 0.0 |
| Acetylcholine binding and downstream events 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acetylcholine neurotransmitter release cycle 1.0 11.0 4.006854838709677 0.2382253475836706 0.0 0.0 0.0 0.0 |
| Acetylcholine regulates insulin secretion 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acrosome reaction and sperm oocyte membrane binding 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated notch1 transmits signal to the nucleus 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk2 signals through cdk5 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk2 signals through frs2 and frs3 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk2 signals through fyn 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk2 signals through pi3k 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk2 signals through ras 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk3 signals through pi3k 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk3 signals through ras 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated pkn1 stimulates transcription of ar androgen receptor regulated genes klk2 and klk3 1.0 14.0 3.081265508684864 0.2927467368934597 0.0 0.0 0.0 0.0 |
| Activated tak1 mediates p38 mapk activation 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of ampk downstream of nmdars 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of anterior hox genes in hindbrain development during early embryogenesis 2.0 60.0 1.3805668016194332 0.4328786381018912 0.0 0.0 0.0 0.0 |
| Activation of atr in response to replication stress 1.0 38.0 1.0799912816041848 0.6098643664363513 0.0 0.0 0.0 0.0 |
| Activation of bad and translocation to mitochondria 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of bh3 only proteins 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of c3 and c5 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of caspases through apoptosome mediated cleavage 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of gene expression by srebf srebp 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of irf3 irf7 mediated by tbk1 ikk epsilon 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of kainate receptors upon glutamate binding 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of matrix metalloproteinases 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of nima kinases nek9 nek6 nek7 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of nmda receptors and postsynaptic events 1.0 68.0 0.594607607125662 0.8149044591247521 0.0 0.0 0.0 0.0 |
| Activation of noxa and translocation to mitochondria 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of ppargc1a pgc 1alpha by phosphorylation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of puma and translocation to mitochondria 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of rac1 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of rac1 downstream of nmdars 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of ras in b cells 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of smo 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of the ap 1 family of transcription factors 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of the mrna upon binding of the cap binding complex and eifs and subsequent binding to 43s 3.0 59.0 2.153963414634146 0.1743155882100804 0.0 0.0 0.0 0.0 |
| Activation of the phototransduction cascade 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of the pre replicative complex 2.0 33.0 2.5900483217970485 0.1923105654227066 0.0 0.0 0.0 0.0 |
| Activation of the tfap2 ap 2 family of transcription factors 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of trka receptors 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodeling of cl 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodeling of dag and tag 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodelling of pc 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodelling of pe 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodelling of pg 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodelling of pi 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodelling of ps 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adaptive immune system 12.0 504.0 0.973036945559329 0.5786549438080232 0.0 0.0 0.0 0.0 |
| Adenylate cyclase activating pathway 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adenylate cyclase inhibitory pathway 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adherens junctions interactions 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adora2b mediated anti inflammatory cytokines production 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adp signalling through p2y purinoceptor 1 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adp signalling through p2y purinoceptor 12 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adrenaline noradrenaline inhibits insulin secretion 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Advanced glycosylation endproduct receptor signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aflatoxin activation and detoxification 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aggrephagy 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Akt phosphorylates targets in the cytosol 1.0 14.0 3.081265508684864 0.2927467368934597 0.0 0.0 0.0 0.0 |
| Akt phosphorylates targets in the nucleus 1.0 9.0 5.009576612903226 0.1995721086637891 0.0 0.0 0.0 0.0 |
| Alk mutants bind tkis 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Alpha defensins 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Alpha linolenic omega3 and linoleic omega6 acid metabolism 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Alpha oxidation of phytanate 1.0 6.0 8.01774193548387 0.1378997973237242 0.0 0.0 0.0 0.0 |
| Alpha protein kinase 1 signaling pathway 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Alternative complement activation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Amino acid transport across the plasma membrane 1.0 17.0 2.502772177419355 0.3433804941091314 0.0 0.0 0.0 0.0 |
| Amino acids regulate mtorc1 1.0 45.0 0.907532991202346 0.6720977570778652 0.0 0.0 0.0 0.0 |
| Ampk inhibits chrebp transcriptional activation activity 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Amyloid fiber formation 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Anchoring fibril formation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Anchoring of the basal body to the plasma membrane 1.0 95.0 0.4226578586135895 0.905566338908512 0.0 0.0 0.0 0.0 |
| Androgen biosynthesis 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Anti inflammatory response favouring leishmania parasite infection 0.0 46.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Antigen activates b cell receptor bcr leading to generation of second messengers 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Antigen presentation folding assembly and peptide loading of class i mhc 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Antigen processing cross presentation 1.0 77.0 0.5237160441426146 0.8520685002809621 0.0 0.0 0.0 0.0 |
| Antigen processing ubiquitination proteasome degradation 4.0 250.0 0.6438360710137714 0.8643974978538252 0.0 0.0 0.0 0.0 |
| Antimicrobial peptides 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Antiviral mechanism by ifn stimulated genes 3.0 73.0 1.7207317073170731 0.2637926657262898 0.0 0.0 0.0 0.0 |
| Apc c cdc20 mediated degradation of cyclin b 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1 0.0 68.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apc c mediated degradation of cell cycle proteins 0.0 81.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apc cdc20 mediated degradation of nek2a 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apex1 independent resolution of ap sites via the single nucleotide replacement pathway 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apobec3g mediated resistance to hiv 1 infection 1.0 4.0 10.0 0.0941782060147337 0.0 0.0 0.0 0.0 |
| Apoptosis 2.0 159.0 0.5049124526161066 0.904064005590068 0.0 0.0 0.0 0.0 |
| Apoptosis induced dna fragmentation 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apoptotic cleavage of cell adhesion proteins 1.0 9.0 5.009576612903226 0.1995721086637891 0.0 0.0 0.0 0.0 |
| Apoptotic cleavage of cellular proteins 1.0 35.0 1.1756404174573054 0.5797145893212095 0.0 0.0 0.0 0.0 |
| Apoptotic execution phase 2.0 47.0 1.781736392262708 0.3191889313297822 0.0 0.0 0.0 0.0 |
| Apoptotic factor mediated response 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aquaporin mediated transport 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Arachidonate production from dag 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Arachidonic acid metabolism 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Arms mediated activation 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aryl hydrocarbon receptor signalling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Asparagine n linked glycosylation 5.0 245.0 0.8288080601092896 0.7192257389003245 0.0 0.0 0.0 0.0 |
| Aspartate and asparagine metabolism 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Assembly and cell surface presentation of nmda receptors 1.0 28.0 1.4814814814814814 0.5000341145668529 0.0 0.0 0.0 0.0 |
| Assembly of active lpl and lipc lipase complexes 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Assembly of collagen fibrils and other multimeric structures 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Assembly of the hiv virion 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Assembly of the orc complex at the origin of replication 1.0 20.0 2.1069609507640066 0.3904027877902372 0.0 0.0 0.0 0.0 |
| Association of tric cct with target proteins during biosynthesis 1.0 36.0 1.1419354838709677 0.5900138775011101 0.0 0.0 0.0 0.0 |
| Asymmetric localization of pcp proteins 0.0 54.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Atf4 activates genes in response to endoplasmic reticulum stress 3.0 22.0 6.37227214377407 0.0157252402213966 0.0 0.0 0.0 0.0 |
| Atf6 atf6 alpha activates chaperone genes 1.0 6.0 8.01774193548387 0.1378997973237242 0.0 0.0 0.0 0.0 |
| Atf6 atf6 alpha activates chaperones 1.0 8.0 5.725806451612903 0.1795191310032965 0.0 0.0 0.0 0.0 |
| Attachment and entry 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Attachment of gpi anchor to upar 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Attenuation phase 1.0 22.0 1.905913978494624 0.4198721048864768 0.0 0.0 0.0 0.0 |
| Auf1 hnrnp d0 binds and destabilizes mrna 1.0 48.0 0.8493479752916953 0.6956428968189323 0.0 0.0 0.0 0.0 |
| Aurka activation by tpx2 0.0 73.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Autophagy 3.0 130.0 0.9429613981179182 0.6194413595670127 0.0 0.0 0.0 0.0 |
| B wich complex positively regulates rrna expression 1.0 45.0 0.907532991202346 0.6720977570778652 0.0 0.0 0.0 0.0 |
| Base excision repair 1.0 55.0 0.7387246117084827 0.7442374898005764 0.0 0.0 0.0 0.0 |
| Base excision repair ap site formation 1.0 23.0 1.819098240469208 0.4340702418800846 0.0 0.0 0.0 0.0 |
| Basigin interactions 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Bbsome mediated cargo targeting to cilium 1.0 18.0 2.355313092979128 0.3594428044513148 0.0 0.0 0.0 0.0 |
| Beta catenin independent wnt signaling 0.0 117.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta catenin phosphorylation cascade 1.0 16.0 2.66989247311828 0.3269170707962712 0.0 0.0 0.0 0.0 |
| Beta oxidation of butanoyl coa to acetyl coa 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of decanoyl coa to octanoyl coa coa 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of hexanoyl coa to butanoyl coa 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of lauroyl coa to decanoyl coa coa 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of octanoyl coa to hexanoyl coa 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of pristanoyl coa 1.0 7.0 6.680779569892473 0.1589658376068851 0.0 0.0 0.0 0.0 |
| Beta oxidation of very long chain fatty acids 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Bh3 only proteins associate with and inactivate anti apoptotic bcl 2 members 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Bicarbonate transporters 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Bile acid and bile salt metabolism 1.0 22.0 1.905913978494624 0.4198721048864768 0.0 0.0 0.0 0.0 |
| Binding and uptake of ligands by scavenger receptors 1.0 17.0 2.502772177419355 0.3433804941091314 0.0 0.0 0.0 0.0 |
| Binding of tcf lef ctnnb1 to target gene promoters 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Biological oxidations 3.0 94.0 1.320825515947467 0.4040959228227282 0.0 0.0 0.0 0.0 |
| Biosynthesis of epa derived spms 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Biosynthesis of maresins 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Biosynthesis of specialized proresolving mediators spms 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Biosynthesis of the n glycan precursor dolichol lipid linked oligosaccharide llo and transfer to a nascent protein 1.0 59.0 0.6875 0.7684505700850466 0.0 0.0 0.0 0.0 |
| Biotin transport and metabolism 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Blood group systems biosynthesis 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Bmal1 clock npas2 activates circadian gene expression 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Branched chain amino acid catabolism 1.0 22.0 1.905913978494624 0.4198721048864768 0.0 0.0 0.0 0.0 |
| Budding and maturation of hiv virion 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Butyrate response factor 1 brf1 binds and destabilizes mrna 3.0 17.0 8.652439024390244 0.0075942890928168 0.0 0.0 0.0 0.0 |
| Butyrophilin btn family interactions 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| C type lectin receptors clrs 2.0 100.0 0.8137651821862348 0.705898059224372 0.0 0.0 0.0 0.0 |
| Ca dependent events 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ca2 pathway 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Calcineurin activates nfat 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Calnexin calreticulin cycle 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Camk iv mediated phosphorylation of creb 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Carboxyterminal post translational modifications of tubulin 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cardiac conduction 0.0 43.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cargo concentration in the er 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cargo recognition for clathrin mediated endocytosis 0.0 78.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cargo trafficking to the periciliary membrane 2.0 43.0 1.9563543003851087 0.2829018108703478 0.0 0.0 0.0 0.0 |
| Carnitine metabolism 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Caspase activation via death receptors in the presence of ligand 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Caspase activation via dependence receptors in the absence of ligand 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Caspase activation via extrinsic apoptotic signalling pathway 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Caspase mediated cleavage of cytoskeletal proteins 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cation coupled chloride cotransporters 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd163 mediating an anti inflammatory response 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd209 dc sign signaling 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd22 mediated bcr regulation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd28 co stimulation 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd28 dependent pi3k akt signaling 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd28 dependent vav1 pathway 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cdc42 gtpase cycle 0.0 134.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cdc6 association with the orc origin complex 1.0 12.0 3.642228739002933 0.256848998879423 0.0 0.0 0.0 0.0 |
| Cdt1 association with the cdc6 orc origin complex 1.0 54.0 0.7527388922702374 0.7378001234946985 0.0 0.0 0.0 0.0 |
| Cell cell communication 2.0 79.0 1.0379094589620903 0.5787343649779384 0.0 0.0 0.0 0.0 |
| Cell cell junction organization 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cell cycle 18.0 613.0 1.224751718869366 0.240989295003523 0.0 0.0 0.0 0.0 |
| Cell cycle checkpoints 5.0 257.0 0.7883652094717668 0.7571582719633807 0.0 0.0 0.0 0.0 |
| Cell cycle mitotic 14.0 498.0 1.1647793212590118 0.3321532652292467 0.0 0.0 0.0 0.0 |
| Cell death signalling via nrage nrif and nade 0.0 63.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cell extracellular matrix interactions 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cell junction organization 0.0 54.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cell surface interactions at the vascular wall 0.0 70.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cellular hexose transport 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cellular response to chemical stress 3.0 133.0 0.9209193245778612 0.6348596253468297 0.0 0.0 0.0 0.0 |
| Cellular response to heat stress 5.0 93.0 2.295780551415797 0.0770567400392524 0.0 0.0 0.0 0.0 |
| Cellular response to hypoxia 0.0 59.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cellular response to starvation 5.0 139.0 1.5006422804012722 0.2525848733650708 0.0 0.0 0.0 0.0 |
| Cellular responses to stimuli 21.0 614.0 1.4528712168279043 0.0737870323485942 0.0 0.0 0.0 0.0 |
| Cellular senescence 2.0 131.0 0.616263377585287 0.8340575855765604 0.0 0.0 0.0 0.0 |
| Cgmp effects 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chaperone mediated autophagy 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chemokine receptors bind chemokines 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chk1 chk2 cds1 mediated inactivation of cyclin b cdk1 complex 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chl1 interactions 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cholesterol biosynthesis 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Choline catabolism 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chondroitin sulfate biosynthesis 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chondroitin sulfate dermatan sulfate metabolism 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chrebp activates metabolic gene expression 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chromatin modifying enzymes 5.0 210.0 0.9738104758096762 0.5861284300292218 0.0 0.0 0.0 0.0 |
| Chromosome maintenance 4.0 100.0 1.6753401360544218 0.2280370158288404 0.0 0.0 0.0 0.0 |
| Chylomicron assembly 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chylomicron clearance 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chylomicron remodeling 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cilium assembly 3.0 183.0 0.6617208672086721 0.8289259261124416 0.0 0.0 0.0 0.0 |
| Circadian clock 1.0 55.0 0.7387246117084827 0.7442374898005764 0.0 0.0 0.0 0.0 |
| Citric acid cycle tca cycle 2.0 21.0 4.230982314084807 0.0920739634299925 0.0 0.0 0.0 0.0 |
| Class a 1 rhodopsin like receptors 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Class b 2 secretin family receptors 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Class i mhc mediated antigen processing presentation 5.0 295.0 0.6823770491803278 0.8520094185375716 0.0 0.0 0.0 0.0 |
| Class i peroxisomal membrane protein import 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Clathrin mediated endocytosis 2.0 119.0 0.6803003564137168 0.7918794564218415 0.0 0.0 0.0 0.0 |
| Clec7a dectin 1 induces nfat activation 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Clec7a dectin 1 signaling 2.0 85.0 0.9622945222184284 0.6187485258432601 0.0 0.0 0.0 0.0 |
| Clec7a inflammasome pathway 1.0 4.0 10.0 0.0941782060147337 0.0 0.0 0.0 0.0 |
| Cobalamin cbl vitamin b12 transport and metabolism 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Coenzyme a biosynthesis 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cohesin loading onto chromatin 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Collagen biosynthesis and modifying enzymes 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Collagen chain trimerization 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Collagen degradation 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Collagen formation 0.0 44.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Common pathway of fibrin clot formation 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Competing endogenous rnas cernas regulate pten translation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Complement cascade 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Complex i biogenesis 3.0 56.0 2.276576161988035 0.1564032996109324 0.0 0.0 0.0 0.0 |
| Condensation of prometaphase chromosomes 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Condensation of prophase chromosomes 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Constitutive signaling by aberrant pi3k in cancer 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Constitutive signaling by akt1 e17k in cancer 2.0 25.0 3.493751100158423 0.123579290468326 0.0 0.0 0.0 0.0 |
| Constitutive signaling by egfrviii 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Constitutive signaling by ligand responsive egfr cancer variants 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Constitutive signaling by overexpressed erbb2 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Conversion from apc c cdc20 to apc c cdh1 in late anaphase 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cooperation of pdcl phlp1 and tric cct in g protein beta folding 1.0 27.0 1.5386166253101736 0.487484567646441 0.0 0.0 0.0 0.0 |
| Cooperation of prefoldin and tric cct in actin and tubulin folding 1.0 28.0 1.4814814814814814 0.5000341145668529 0.0 0.0 0.0 0.0 |
| Copi dependent golgi to er retrograde traffic 2.0 83.0 0.9862548108162144 0.6057425419074338 0.0 0.0 0.0 0.0 |
| Copi independent golgi to er retrograde traffic 2.0 45.0 1.8649844647396667 0.3010844649684869 0.0 0.0 0.0 0.0 |
| Copi mediated anterograde transport 4.0 89.0 1.8942617046818728 0.1727170115710306 0.0 0.0 0.0 0.0 |
| Copii mediated vesicle transport 0.0 55.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Costimulation by the cd28 family 1.0 39.0 1.0514643463497453 0.6194276439258724 0.0 0.0 0.0 0.0 |
| Creatine metabolism 1.0 6.0 8.01774193548387 0.1378997973237242 0.0 0.0 0.0 0.0 |
| Creb phosphorylation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Creb1 phosphorylation through nmda receptor mediated activation of ras signaling 1.0 21.0 2.0014112903225807 0.4053192290166058 0.0 0.0 0.0 0.0 |
| Creb1 phosphorylation through the activation of adenylate cyclase 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Creb1 phosphorylation through the activation of camkii camkk camkiv cascasde 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Creb3 factors activate genes 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cristae formation 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Crmps in sema3a signaling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cross presentation of particulate exogenous antigens phagosomes 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cross presentation of soluble exogenous antigens endosomes 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Crosslinking of collagen fibrils 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cs ds degradation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ctla4 inhibitory signaling 1.0 17.0 2.502772177419355 0.3433804941091314 0.0 0.0 0.0 0.0 |
| Cyclin a b1 b2 associated events during g2 m transition 1.0 24.0 1.7398316970546983 0.4479222530759854 0.0 0.0 0.0 0.0 |
| Cyclin a cdk2 associated events at s phase entry 0.0 79.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cyclin d associated events in g1 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cyp2e1 reactions 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cytochrome c mediated apoptotic response 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cytochrome p450 arranged by substrate type 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cytokine signaling in immune system 14.0 392.0 1.5081166272655635 0.0994952478412019 0.0 0.0 0.0 0.0 |
| Cytoprotection by hmox1 2.0 110.0 0.737666816614185 0.7543165032330819 0.0 0.0 0.0 0.0 |
| Cytosolic iron sulfur cluster assembly 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cytosolic sensors of pathogen associated dna 2.0 56.0 1.4834307992202729 0.3988408250989342 0.0 0.0 0.0 0.0 |
| Cytosolic sulfonation of small molecules 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cytosolic trna aminoacylation 1.0 24.0 1.7398316970546983 0.4479222530759854 0.0 0.0 0.0 0.0 |
| Dag and ip3 signaling 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dap12 interactions 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dap12 signaling 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Darpp 32 events 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dcc mediated attractive signaling 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ddx58 ifih1 mediated induction of interferon alpha beta 1.0 57.0 0.7121975806451613 0.7566437763344733 0.0 0.0 0.0 0.0 |
| Deactivation of the beta catenin transactivating complex 3.0 36.0 3.663710273466371 0.0569111676931314 0.0 0.0 0.0 0.0 |
| Deadenylation dependent mrna decay 7.0 57.0 5.725537190082645 0.0004442369263605 0.0 0.0 0.0 0.0 |
| Deadenylation of mrna 1.0 26.0 1.6003225806451613 0.4746213136734084 0.0 0.0 0.0 0.0 |
| Death receptor signalling 2.0 120.0 0.6744664791051945 0.7957255921131816 0.0 0.0 0.0 0.0 |
| Dectin 1 mediated noncanonical nf kb signaling 1.0 53.0 0.7672921836228288 0.7312014000904572 0.0 0.0 0.0 0.0 |
| Dectin 2 family 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective b4galt1 causes b4galt1 cdg cdg 2d 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective b4galt7 causes eds progeroid type 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective c1galt1c1 causes tnps 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective cftr causes cystic fibrosis 0.0 54.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective chst14 causes eds musculocontractural type 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective chst3 causes sedcjd 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective chst6 causes mcdc1 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective chsy1 causes tpbs 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective ext2 causes exostoses 2 1.0 11.0 4.006854838709677 0.2382253475836706 0.0 0.0 0.0 0.0 |
| Defective f9 activation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective factor ix causes hemophilia b 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective factor viii causes hemophilia a 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective galnt3 causes hftc 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective intrinsic pathway for apoptosis 1.0 24.0 1.7398316970546983 0.4479222530759854 0.0 0.0 0.0 0.0 |
| Defective lfng causes scdo3 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective ripk1 mediated regulated necrosis 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defects in biotin btn metabolism 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defects in cobalamin b12 metabolism 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defects in vitamin and cofactor metabolism 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defects of contact activation system cas and kallikrein kinin system kks 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defensins 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Degradation of axin 0.0 48.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Degradation of beta catenin by the destruction complex 3.0 77.0 1.6270599868160844 0.2904366558767694 0.0 0.0 0.0 0.0 |
| Degradation of cysteine and homocysteine 1.0 12.0 3.642228739002933 0.256848998879423 0.0 0.0 0.0 0.0 |
| Degradation of dvl 0.0 50.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Degradation of gli1 by the proteasome 0.0 53.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Degradation of the extracellular matrix 2.0 56.0 1.4834307992202729 0.3988408250989342 0.0 0.0 0.0 0.0 |
| Depolymerisation of the nuclear lamina 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Deposition of new cenpa containing nucleosomes at the centromere 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dermatan sulfate biosynthesis 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Detoxification of reactive oxygen species 1.0 24.0 1.7398316970546983 0.4479222530759854 0.0 0.0 0.0 0.0 |
| Deubiquitination 1.0 221.0 0.1782807917888563 0.9960128650619148 0.0 0.0 0.0 0.0 |
| Developmental biology 21.0 665.0 1.330520594965675 0.1353088700982837 0.0 0.0 0.0 0.0 |
| Dex h box helicases activate type i ifn and inflammatory cytokines production 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Digestion 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Digestion and absorption 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Disassembly of the destruction complex and recruitment of axin to the membrane 1.0 24.0 1.7398316970546983 0.4479222530759854 0.0 0.0 0.0 0.0 |
| Diseases associated with glycosaminoglycan metabolism 1.0 26.0 1.6003225806451613 0.4746213136734084 0.0 0.0 0.0 0.0 |
| Diseases associated with glycosylation precursor biosynthesis 1.0 16.0 2.66989247311828 0.3269170707962712 0.0 0.0 0.0 0.0 |
| Diseases associated with n glycosylation of proteins 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases associated with o glycosylation of proteins 1.0 17.0 2.502772177419355 0.3433804941091314 0.0 0.0 0.0 0.0 |
| Diseases associated with surfactant metabolism 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of base excision repair 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of carbohydrate metabolism 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of dna repair 1.0 33.0 1.2493699596774193 0.558336601374079 0.0 0.0 0.0 0.0 |
| Diseases of glycosylation 3.0 76.0 1.649515536251253 0.2837526308775903 0.0 0.0 0.0 0.0 |
| Diseases of immune system 1.0 15.0 2.860887096774193 0.3100425591757577 0.0 0.0 0.0 0.0 |
| Diseases of metabolism 4.0 131.0 1.26241362686807 0.3980949716927166 0.0 0.0 0.0 0.0 |
| Diseases of mismatch repair mmr 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of mitotic cell cycle 1.0 38.0 1.0799912816041848 0.6098643664363513 0.0 0.0 0.0 0.0 |
| Diseases of programmed cell death 3.0 53.0 2.4139024390243904 0.1391149976670843 0.0 0.0 0.0 0.0 |
| Diseases of signal transduction by growth factor receptors and second messengers 10.0 333.0 1.2466805704884905 0.2966436684655956 0.0 0.0 0.0 0.0 |
| Disinhibition of snare formation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Disorders of transmembrane transporters 2.0 115.0 0.7046684103041811 0.7758522926920045 0.0 0.0 0.0 0.0 |
| Displacement of dna glycosylase by apex1 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dissolution of fibrin clot 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna damage bypass 0.0 49.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna damage recognition in gg ner 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna damage reversal 1.0 8.0 5.725806451612903 0.1795191310032965 0.0 0.0 0.0 0.0 |
| Dna damage telomere stress induced senescence 1.0 38.0 1.0799912816041848 0.6098643664363513 0.0 0.0 0.0 0.0 |
| Dna double strand break repair 3.0 137.0 0.8930651619949035 0.654736205251673 0.0 0.0 0.0 0.0 |
| Dna double strand break response 0.0 49.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna methylation 1.0 14.0 3.081265508684864 0.2927467368934597 0.0 0.0 0.0 0.0 |
| Dna repair 7.0 291.0 0.9841840297986264 0.570390309065962 0.0 0.0 0.0 0.0 |
| Dna replication 2.0 137.0 0.5885140200929675 0.8521237050549726 0.0 0.0 0.0 0.0 |
| Dna replication initiation 1.0 8.0 5.725806451612903 0.1795191310032965 0.0 0.0 0.0 0.0 |
| Dna replication pre initiation 2.0 92.0 0.8868196131354026 0.6616731736307409 0.0 0.0 0.0 0.0 |
| Dna strand elongation 1.0 35.0 1.1756404174573054 0.5797145893212095 0.0 0.0 0.0 0.0 |
| Dopamine clearance from the synaptic cleft 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dopamine neurotransmitter release cycle 1.0 18.0 2.355313092979128 0.3594428044513148 0.0 0.0 0.0 0.0 |
| Downregulation of erbb2 erbb3 signaling 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downregulation of erbb2 signaling 1.0 18.0 2.355313092979128 0.3594428044513148 0.0 0.0 0.0 0.0 |
| Downregulation of erbb4 signaling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downregulation of smad2 3 smad4 transcriptional activity 2.0 23.0 3.8272604588394064 0.1075130907868997 0.0 0.0 0.0 0.0 |
| Downregulation of tgf beta receptor signaling 1.0 22.0 1.905913978494624 0.4198721048864768 0.0 0.0 0.0 0.0 |
| Downstream signal transduction 1.0 23.0 1.819098240469208 0.4340702418800846 0.0 0.0 0.0 0.0 |
| Downstream signaling events of b cell receptor bcr 2.0 71.0 1.159185589391539 0.5207614848352471 0.0 0.0 0.0 0.0 |
| Downstream signaling of activated fgfr1 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downstream signaling of activated fgfr2 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downstream signaling of activated fgfr3 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downstream signaling of activated fgfr4 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dscam interactions 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dual incision in gg ner 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dual incision in tc ner 1.0 67.0 0.603677908113392 0.8102396018793399 0.0 0.0 0.0 0.0 |
| E2f enabled inhibition of pre replication complex formation 1.0 10.0 4.452508960573477 0.2191369015278419 0.0 0.0 0.0 0.0 |
| E2f mediated regulation of dna replication 2.0 23.0 3.8272604588394064 0.1075130907868997 0.0 0.0 0.0 0.0 |
| E3 ubiquitin ligases ubiquitinate target proteins 2.0 40.0 2.111442574046452 0.2555664496894125 0.0 0.0 0.0 0.0 |
| Early phase of hiv life cycle 2.0 13.0 7.313949208686051 0.0388074443523606 0.0 0.0 0.0 0.0 |
| Ecm proteoglycans 1.0 37.0 1.1101030465949822 0.6000617657406979 0.0 0.0 0.0 0.0 |
| Effects of pip2 hydrolysis 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Egfr downregulation 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Egfr interacts with phospholipase c gamma 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Egfr transactivation by gastrin 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Egr2 and sox10 mediated initiation of schwann cell myelination 1.0 20.0 2.1069609507640066 0.3904027877902372 0.0 0.0 0.0 0.0 |
| Eicosanoids 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Elastic fibre formation 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Electric transmission across gap junctions 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Elevation of cytosolic ca2 levels 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Endogenous sterols 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Endosomal sorting complex required for transport escrt 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Endosomal vacuolar pathway 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Energy dependent regulation of mtor by lkb1 ampk 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Enos activation 1.0 7.0 6.680779569892473 0.1589658376068851 0.0 0.0 0.0 0.0 |
| Eph ephrin mediated repulsion of cells 1.0 43.0 0.9509408602150538 0.6554018259586739 0.0 0.0 0.0 0.0 |
| Eph ephrin signaling 2.0 80.0 1.0244991176165266 0.5856109356495672 0.0 0.0 0.0 0.0 |
| Epha mediated growth cone collapse 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ephb mediated forward signaling 1.0 40.0 1.0244003308519438 0.6287574181217924 0.0 0.0 0.0 0.0 |
| Ephrin signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Epigenetic regulation of gene expression 6.0 102.0 2.53369341563786 0.0385618829400607 0.0 0.0 0.0 0.0 |
| Er quality control compartment erqc 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Er to golgi anterograde transport 4.0 129.0 1.282873469387755 0.3869979371807045 0.0 0.0 0.0 0.0 |
| Erbb2 activates ptk6 signaling 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erbb2 regulates cell motility 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ercc6 csb and ehmt2 g9a positively regulate rrna expression 2.0 27.0 3.213603238866397 0.1401767104122509 0.0 0.0 0.0 0.0 |
| Erk mapk targets 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erks are inactivated 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythrocytes take up carbon dioxide and release oxygen 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythrocytes take up oxygen and release carbon dioxide 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythropoietin activates phosphoinositide 3 kinase pi3k 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythropoietin activates phospholipase c gamma plcg 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythropoietin activates ras 1.0 11.0 4.006854838709677 0.2382253475836706 0.0 0.0 0.0 0.0 |
| Erythropoietin activates stat5 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Esr mediated signaling 8.0 136.0 2.546421161825726 0.0182716334744495 0.0 0.0 0.0 0.0 |
| Establishment of sister chromatid cohesion 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Estrogen biosynthesis 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Estrogen dependent gene expression 5.0 90.0 2.3775313404050147 0.0689992708703911 0.0 0.0 0.0 0.0 |
| Estrogen dependent nuclear events downstream of esr membrane signaling 2.0 15.0 6.187480535658674 0.0506052248933858 0.0 0.0 0.0 0.0 |
| Estrogen stimulated signaling through prkcz 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ethanol oxidation 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Eukaryotic translation elongation 4.0 89.0 1.8942617046818728 0.1727170115710306 0.0 0.0 0.0 0.0 |
| Eukaryotic translation initiation 5.0 116.0 1.8158322256682915 0.1540990039001299 0.0 0.0 0.0 0.0 |
| Export of viral ribonucleoproteins from nucleus 3.0 32.0 4.170731707317073 0.0424141111811751 0.0 0.0 0.0 0.0 |
| Extension of telomeres 2.0 52.0 1.6027530364372469 0.3638889950068242 0.0 0.0 0.0 0.0 |
| Extra nuclear estrogen signaling 3.0 47.0 2.7447339246119733 0.1067440658746814 0.0 0.0 0.0 0.0 |
| Extracellular matrix organization 2.0 131.0 0.616263377585287 0.8340575855765604 0.0 0.0 0.0 0.0 |
| Extrinsic pathway of fibrin clot formation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Factors involved in megakaryocyte development and platelet production 5.0 117.0 1.799436475409836 0.1580015049987725 0.0 0.0 0.0 0.0 |
| Fanconi anemia pathway 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fasl cd95l signaling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fatty acid metabolism 2.0 117.0 0.6922724872381623 0.7839959020157817 0.0 0.0 0.0 0.0 |
| Fatty acids bound to gpr40 ffar1 regulate insulin secretion 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fatty acyl coa biosynthesis 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fbxw7 mutants and notch1 in cancer 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fc epsilon receptor fceri signaling 2.0 108.0 0.7517378351539226 0.7452161531552387 0.0 0.0 0.0 0.0 |
| Fceri mediated ca 2 mobilization 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fceri mediated mapk activation 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fceri mediated nf kb activation 2.0 68.0 1.2122438964544229 0.4976941658352568 0.0 0.0 0.0 0.0 |
| Fcgamma receptor fcgr dependent phagocytosis 1.0 72.0 0.560881417537483 0.8324491478377668 0.0 0.0 0.0 0.0 |
| Fcgr activation 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fcgr3a mediated il10 synthesis 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fertilization 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr1 ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr1 mutant receptor activation 1.0 22.0 1.905913978494624 0.4198721048864768 0.0 0.0 0.0 0.0 |
| Fgfr1b ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr1c ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr2 alternative splicing 1.0 26.0 1.6003225806451613 0.4746213136734084 0.0 0.0 0.0 0.0 |
| Fgfr2 ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr2 mutant receptor activation 1.0 18.0 2.355313092979128 0.3594428044513148 0.0 0.0 0.0 0.0 |
| Fgfr2b ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr2c ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr3 ligand binding and activation 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr3b ligand binding and activation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfrl1 modulation of fgfr1 signaling 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fibronectin matrix formation 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Flt3 signaling 1.0 27.0 1.5386166253101736 0.487484567646441 0.0 0.0 0.0 0.0 |
| Flt3 signaling by cbl mutants 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Flt3 signaling in disease 1.0 22.0 1.905913978494624 0.4198721048864768 0.0 0.0 0.0 0.0 |
| Flt3 signaling through src family kinases 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Folding of actin by cct tric 1.0 10.0 4.452508960573477 0.2191369015278419 0.0 0.0 0.0 0.0 |
| Formation of apoptosome 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of atp by chemiosmotic coupling 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of fibrin clot clotting cascade 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of incision complex in gg ner 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of rna pol ii elongation complex 4.0 58.0 2.9910808767951624 0.0528261722730647 0.0 0.0 0.0 0.0 |
| Formation of senescence associated heterochromatin foci sahf 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of tc ner pre incision complex 1.0 53.0 0.7672921836228288 0.7312014000904572 0.0 0.0 0.0 0.0 |
| Formation of the beta catenin tcf transactivating complex 1.0 38.0 1.0799912816041848 0.6098643664363513 0.0 0.0 0.0 0.0 |
| Formation of the cornified envelope 1.0 24.0 1.7398316970546983 0.4479222530759854 0.0 0.0 0.0 0.0 |
| Formation of the early elongation complex 1.0 33.0 1.2493699596774193 0.558336601374079 0.0 0.0 0.0 0.0 |
| Formation of tubulin folding intermediates by cct tric 1.0 21.0 2.0014112903225807 0.4053192290166058 0.0 0.0 0.0 0.0 |
| Formation of xylulose 5 phosphate 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formyl peptide receptors bind formyl peptides and many other ligands 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Foxo mediated transcription 3.0 47.0 2.7447339246119733 0.1067440658746814 0.0 0.0 0.0 0.0 |
| Foxo mediated transcription of cell cycle genes 1.0 13.0 3.3383736559139785 0.2750191284248381 0.0 0.0 0.0 0.0 |
| Foxo mediated transcription of cell death genes 1.0 12.0 3.642228739002933 0.256848998879423 0.0 0.0 0.0 0.0 |
| Foxo mediated transcription of oxidative stress metabolic and neuronal genes 2.0 18.0 5.02580971659919 0.0703212183088513 0.0 0.0 0.0 0.0 |
| Free fatty acids regulate insulin secretion 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Frs mediated fgfr1 signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Frs mediated fgfr2 signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Frs mediated fgfr3 signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Frs mediated fgfr4 signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fructose catabolism 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fructose metabolism 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G alpha 12 13 signalling events 0.0 57.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G alpha i signalling events 1.0 88.0 0.4569892473118279 0.8875456676712974 0.0 0.0 0.0 0.0 |
| G alpha q signalling events 0.0 66.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G alpha s signalling events 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G alpha z signalling events 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G beta gamma signalling through cdc42 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G beta gamma signalling through pi3kgamma 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G protein activation 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G protein beta gamma signalling 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G protein mediated events 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G0 and early g1 1.0 26.0 1.6003225806451613 0.4746213136734084 0.0 0.0 0.0 0.0 |
| G1 s dna damage checkpoints 0.0 61.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G1 s specific transcription 2.0 29.0 2.9749587644324484 0.157217223036351 0.0 0.0 0.0 0.0 |
| G2 m checkpoints 1.0 134.0 0.2975382003395586 0.9643909176169584 0.0 0.0 0.0 0.0 |
| G2 m dna damage checkpoint 0.0 66.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G2 m dna replication checkpoint 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G2 phase 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gab1 signalosome 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gaba b receptor activation 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gaba receptor activation 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gaba synthesis release reuptake and degradation 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Galactose catabolism 1.0 5.0 10.0 0.1163082714273898 0.0 0.0 0.0 0.0 |
| Gamma carboxylation hypusine formation and arylsulfatase activation 1.0 29.0 1.4284274193548387 0.5122775749816724 0.0 0.0 0.0 0.0 |
| Gamma carboxylation transport and amino terminal cleavage of proteins 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gap filling dna repair synthesis and ligation in gg ner 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gap junction assembly 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gap junction degradation 1.0 12.0 3.642228739002933 0.256848998879423 0.0 0.0 0.0 0.0 |
| Gap junction trafficking and regulation 1.0 28.0 1.4814814814814814 0.5000341145668529 0.0 0.0 0.0 0.0 |
| Gastrin creb signalling pathway via pkc and mapk 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gdp fucose biosynthesis 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gene and protein expression by jak stat signaling after interleukin 12 stimulation 1.0 33.0 1.2493699596774193 0.558336601374079 0.0 0.0 0.0 0.0 |
| Gene silencing by rna 3.0 75.0 1.6725948509485096 0.2770823582814727 0.0 0.0 0.0 0.0 |
| Generation of second messenger molecules 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gli proteins bind promoters of hh responsive genes to promote transcription 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Global genome nucleotide excision repair gg ner 0.0 87.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glucagon like peptide 1 glp1 regulates insulin secretion 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glucagon signaling in metabolic regulation 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glucagon type ligand receptors 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gluconeogenesis 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glucose metabolism 6.0 80.0 3.294294294294294 0.0133275956191841 0.0 0.0 0.0 0.0 |
| Glucuronidation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glutamate and glutamine metabolism 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glutamate neurotransmitter release cycle 1.0 17.0 2.502772177419355 0.3433804941091314 0.0 0.0 0.0 0.0 |
| Glutathione conjugation 2.0 21.0 4.230982314084807 0.0920739634299925 0.0 0.0 0.0 0.0 |
| Glutathione synthesis and recycling 1.0 8.0 5.725806451612903 0.1795191310032965 0.0 0.0 0.0 0.0 |
| Glycerophospholipid biosynthesis 0.0 86.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycerophospholipid catabolism 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycogen breakdown glycogenolysis 1.0 13.0 3.3383736559139785 0.2750191284248381 0.0 0.0 0.0 0.0 |
| Glycogen metabolism 1.0 20.0 2.1069609507640066 0.3904027877902372 0.0 0.0 0.0 0.0 |
| Glycogen storage diseases 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycogen synthesis 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycolysis 6.0 66.0 4.068724279835391 0.0053374430593766 0.0 0.0 0.0 0.0 |
| Glycosaminoglycan metabolism 1.0 70.0 0.5772557269752221 0.8238942805650689 0.0 0.0 0.0 0.0 |
| Glycosphingolipid metabolism 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glyoxylate metabolism and glycine degradation 1.0 22.0 1.905913978494624 0.4198721048864768 0.0 0.0 0.0 0.0 |
| Golgi associated vesicle biogenesis 0.0 55.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Golgi cisternae pericentriolar stack reorganization 1.0 14.0 3.081265508684864 0.2927467368934597 0.0 0.0 0.0 0.0 |
| Golgi to er retrograde transport 4.0 115.0 1.446736532450818 0.3091224958085361 0.0 0.0 0.0 0.0 |
| Gp1b ix v activation signalling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gpcr ligand binding 0.0 46.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gpvi mediated activation cascade 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Grb2 events in erbb2 signaling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Grb2 sos provides linkage to mapk signaling for integrins 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Grb7 events in erbb2 signaling 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Growth hormone receptor signaling 1.0 15.0 2.860887096774193 0.3100425591757577 0.0 0.0 0.0 0.0 |
| Hats acetylate histones 1.0 90.0 0.446629213483146 0.8930180836943507 0.0 0.0 0.0 0.0 |
| Hcmv early events 3.0 79.0 1.583921694480103 0.3038366592016079 0.0 0.0 0.0 0.0 |
| Hcmv infection 4.0 102.0 1.6408163265306122 0.238552463510868 0.0 0.0 0.0 0.0 |
| Hcmv late events 3.0 62.0 2.0438197602315005 0.1927694592715518 0.0 0.0 0.0 0.0 |
| Hdacs deacetylate histones 2.0 40.0 2.111442574046452 0.2555664496894125 0.0 0.0 0.0 0.0 |
| Hdl assembly 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdl clearance 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdl remodeling 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdms demethylate histones 2.0 25.0 3.493751100158423 0.123579290468326 0.0 0.0 0.0 0.0 |
| Hdr through homologous recombination hrr 1.0 66.0 0.6130272952853598 0.8054576628796468 0.0 0.0 0.0 0.0 |
| Hdr through mmej alt nhej 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdr through single strand annealing ssa 1.0 35.0 1.1756404174573054 0.5797145893212095 0.0 0.0 0.0 0.0 |
| Hedgehog ligand biogenesis 0.0 53.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hedgehog off state 0.0 96.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hedgehog on state 0.0 70.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Heme biosynthesis 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Heme degradation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Heme signaling 2.0 36.0 2.3608001905215525 0.2192395028209926 0.0 0.0 0.0 0.0 |
| Hemostasis 10.0 361.0 1.1438925246456628 0.3875518603135806 0.0 0.0 0.0 0.0 |
| Heparan sulfate heparin hs gag metabolism 1.0 32.0 1.289802289281998 0.5472449033122827 0.0 0.0 0.0 0.0 |
| Highly calcium permeable nicotinic acetylcholine receptors 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Histidine catabolism 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hiv elongation arrest and recovery 3.0 32.0 4.170731707317073 0.0424141111811751 0.0 0.0 0.0 0.0 |
| Hiv infection 10.0 213.0 2.00836820083682 0.036134825021278 0.0 0.0 0.0 0.0 |
| Hiv life cycle 9.0 144.0 2.725555555555556 0.0087222290719469 0.0 0.0 0.0 0.0 |
| Hiv transcription elongation 3.0 42.0 3.098186366479049 0.0824073873197279 0.0 0.0 0.0 0.0 |
| Hiv transcription initiation 2.0 45.0 1.8649844647396667 0.3010844649684869 0.0 0.0 0.0 0.0 |
| Homologous dna pairing and strand exchange 1.0 41.0 0.9986895161290322 0.63785936798976 0.0 0.0 0.0 0.0 |
| Homology directed repair 1.0 106.0 0.3779569892473118 0.9282490969617072 0.0 0.0 0.0 0.0 |
| Host interactions of hiv factors 6.0 116.0 2.208080808080808 0.0645144646592173 0.0 0.0 0.0 0.0 |
| Hs gag biosynthesis 1.0 17.0 2.502772177419355 0.3433804941091314 0.0 0.0 0.0 0.0 |
| Hs gag degradation 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hsf1 activation 1.0 25.0 1.6671706989247312 0.4614365431795375 0.0 0.0 0.0 0.0 |
| Hsf1 dependent transactivation 1.0 30.0 1.3790322580645162 0.5242223850322378 0.0 0.0 0.0 0.0 |
| Hsp90 chaperone cycle for steroid hormone receptors shr in the presence of ligand 1.0 47.0 0.8678997194950911 0.6879878545074485 0.0 0.0 0.0 0.0 |
| Hur elavl1 binds and stabilizes mrna 1.0 7.0 6.680779569892473 0.1589658376068851 0.0 0.0 0.0 0.0 |
| Hyaluronan biosynthesis and export 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hyaluronan metabolism 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hyaluronan uptake and degradation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hydrolysis of lpc 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ikba variant leads to eda id 1.0 7.0 6.680779569892473 0.1589658376068851 0.0 0.0 0.0 0.0 |
| Ikk complex recruitment mediated by rip1 1.0 16.0 2.66989247311828 0.3269170707962712 0.0 0.0 0.0 0.0 |
| Il 6 type cytokine receptor ligand interactions 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Immunoregulatory interactions between a lymphoid and a non lymphoid cell 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Inactivation of cdc42 and rac1 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Inactivation of csf3 g csf signaling 1.0 17.0 2.502772177419355 0.3433804941091314 0.0 0.0 0.0 0.0 |
| Incretin synthesis secretion and inactivation 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Infection with mycobacterium tuberculosis 1.0 21.0 2.0014112903225807 0.4053192290166058 0.0 0.0 0.0 0.0 |
| Infectious disease 22.0 619.0 1.5178683431843505 0.0488543140954342 0.0 0.0 0.0 0.0 |
| Inflammasomes 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Influenza infection 9.0 150.0 2.607978723404256 0.0112298746624133 0.0 0.0 0.0 0.0 |
| Inhibition of dna recombination at telomere 3.0 28.0 4.84 0.0300655360870906 0.0 0.0 0.0 0.0 |
| Inhibition of replication initiation of damaged dna by rb1 e2f1 1.0 13.0 3.3383736559139785 0.2750191284248381 0.0 0.0 0.0 0.0 |
| Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Initial triggering of complement 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Initiation of nuclear envelope ne reformation 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Inla mediated entry of listeria monocytogenes into host cells 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Inlb mediated entry of listeria monocytogenes into host cell 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Innate immune system 15.0 624.0 0.9829059829059827 0.5640881860070992 0.0 0.0 0.0 0.0 |
| Inositol phosphate metabolism 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Insertion of tail anchored proteins into the endoplasmic reticulum membrane 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Insulin processing 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Insulin receptor recycling 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Insulin receptor signalling cascade 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Integration of energy metabolism 0.0 71.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Integration of provirus 2.0 9.0 10.0 0.0190953097419897 0.0 0.0 0.0 0.0 |
| Integrin cell surface interactions 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Integrin signaling 1.0 18.0 2.355313092979128 0.3594428044513148 0.0 0.0 0.0 0.0 |
| Interaction between l1 and ankyrins 2.0 12.0 8.046153846153846 0.0333651833289618 0.0 0.0 0.0 0.0 |
| Interaction with cumulus cells and the zona pellucida 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interactions of rev with host cellular proteins 3.0 37.0 3.555595408895265 0.0608575356821196 0.0 0.0 0.0 0.0 |
| Interactions of vpr with host cellular proteins 3.0 37.0 3.555595408895265 0.0608575356821196 0.0 0.0 0.0 0.0 |
| Interconversion of nucleotide di and triphosphates 3.0 26.0 5.261930010604454 0.0247234076565489 0.0 0.0 0.0 0.0 |
| Interferon alpha beta signaling 1.0 31.0 1.3329301075268818 0.5358758009484922 0.0 0.0 0.0 0.0 |
| Interferon gamma signaling 1.0 51.0 0.7981451612903225 0.7175036707273205 0.0 0.0 0.0 0.0 |
| Interferon signaling 4.0 128.0 1.2933508887425935 0.3814396802786637 0.0 0.0 0.0 0.0 |
| Interleukin 1 family signaling 3.0 95.0 1.306336161187699 0.4106758023969134 0.0 0.0 0.0 0.0 |
| Interleukin 1 processing 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 1 signaling 2.0 82.0 0.9986842105263158 0.5991150617982537 0.0 0.0 0.0 0.0 |
| Interleukin 10 signaling 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 12 family signaling 1.0 43.0 0.9509408602150538 0.6554018259586739 0.0 0.0 0.0 0.0 |
| Interleukin 12 signaling 1.0 38.0 1.0799912816041848 0.6098643664363513 0.0 0.0 0.0 0.0 |
| Interleukin 15 signaling 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 17 signaling 2.0 57.0 1.456312108943688 0.4074419886033491 0.0 0.0 0.0 0.0 |
| Interleukin 2 family signaling 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 2 signaling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 20 family signaling 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 21 signaling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 23 signaling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 27 signaling 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 3 interleukin 5 and gm csf signaling 1.0 31.0 1.3329301075268818 0.5358758009484922 0.0 0.0 0.0 0.0 |
| Interleukin 35 signalling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 36 pathway 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 37 signaling 1.0 12.0 3.642228739002933 0.256848998879423 0.0 0.0 0.0 0.0 |
| Interleukin 4 and interleukin 13 signaling 3.0 40.0 3.2663150955833884 0.0734338910721259 0.0 0.0 0.0 0.0 |
| Interleukin 6 family signaling 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 6 signaling 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 7 signaling 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 9 signaling 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin receptor shc signaling 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Intra golgi and retrograde golgi to er traffic 4.0 181.0 0.9011875936815404 0.6493049402517124 0.0 0.0 0.0 0.0 |
| Intra golgi traffic 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Intracellular signaling by second messengers 6.0 233.0 1.0572687224669604 0.5061083858409456 0.0 0.0 0.0 0.0 |
| Intraflagellar transport 0.0 48.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Intrinsic pathway for apoptosis 0.0 53.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Intrinsic pathway of fibrin clot formation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Inwardly rectifying k channels 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ion channel transport 0.0 82.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ion homeostasis 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ion transport by p type atpases 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ionotropic activity of kainate receptors 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irak1 recruits ikk complex 1.0 12.0 3.642228739002933 0.256848998879423 0.0 0.0 0.0 0.0 |
| Irak2 mediated activation of tak1 complex 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irak4 deficiency tlr2 4 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ire1alpha activates chaperones 0.0 44.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irf3 mediated activation of type 1 ifn 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irf3 mediated induction of type i ifn 1.0 8.0 5.725806451612903 0.1795191310032965 0.0 0.0 0.0 0.0 |
| Iron uptake and transport 0.0 38.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irs activation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irs mediated signalling 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Jnk c jun kinases phosphorylation and activation mediated by activated human tak1 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Josephin domain dubs 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Keratan sulfate biosynthesis 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Keratan sulfate degradation 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Keratan sulfate keratin metabolism 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Keratinization 1.0 24.0 1.7398316970546983 0.4479222530759854 0.0 0.0 0.0 0.0 |
| Ketone body metabolism 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Killing mechanisms 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Kinesins 1.0 47.0 0.8678997194950911 0.6879878545074485 0.0 0.0 0.0 0.0 |
| Ksrp khsrp binds and destabilizes mrna 3.0 17.0 8.652439024390244 0.0075942890928168 0.0 0.0 0.0 0.0 |
| L1cam interactions 7.0 91.0 3.396349862258953 0.0067559961712648 0.0 0.0 0.0 0.0 |
| Lagging strand synthesis 1.0 23.0 1.819098240469208 0.4340702418800846 0.0 0.0 0.0 0.0 |
| Laminin interactions 1.0 23.0 1.819098240469208 0.4340702418800846 0.0 0.0 0.0 0.0 |
| Late endosomal microautophagy 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ldl clearance 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ldl remodeling 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Leishmania infection 1.0 110.0 0.3639390352175199 0.935074829661498 0.0 0.0 0.0 0.0 |
| Lgi adam interactions 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ligand receptor interactions 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Linoleic acid la metabolism 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lipid particle organization 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lipophagy 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Listeria monocytogenes entry into host cells 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Long term potentiation 1.0 11.0 4.006854838709677 0.2382253475836706 0.0 0.0 0.0 0.0 |
| Loss of function of mecp2 in rett syndrome 1.0 12.0 3.642228739002933 0.256848998879423 0.0 0.0 0.0 0.0 |
| Loss of function of smad2 3 in cancer 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Loss of mecp2 binding ability to the ncor smrt complex 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lrr flii interacting protein 1 lrrfip1 activates type i ifn production 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lysine catabolism 1.0 11.0 4.006854838709677 0.2382253475836706 0.0 0.0 0.0 0.0 |
| Lysosome vesicle biogenesis 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lysosphingolipid and lpa receptors 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| M phase 10.0 355.0 1.164513977320963 0.3677469114047727 0.0 0.0 0.0 0.0 |
| Map2k and mapk activation 1.0 31.0 1.3329301075268818 0.5358758009484922 0.0 0.0 0.0 0.0 |
| Map3k8 tpl2 dependent mapk1 3 activation 2.0 14.0 6.703778677462888 0.0445602183527292 0.0 0.0 0.0 0.0 |
| Mapk family signaling cascades 9.0 212.0 1.8 0.0756354768381402 0.0 0.0 0.0 0.0 |
| Mapk targets nuclear events mediated by map kinases 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mapk1 erk2 activation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mapk3 erk1 activation 1.0 8.0 5.725806451612903 0.1795191310032965 0.0 0.0 0.0 0.0 |
| Mapk6 mapk4 signaling 3.0 77.0 1.6270599868160844 0.2904366558767694 0.0 0.0 0.0 0.0 |
| Mastl facilitates mitotic progression 1.0 10.0 4.452508960573477 0.2191369015278419 0.0 0.0 0.0 0.0 |
| Maturation of protein 3a 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Maturation of sars cov 1 nucleoprotein 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Maturation of sars cov 1 spike protein 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Maturation of sars cov 2 nucleoprotein 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Maturation of sars cov 2 spike protein 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mecp2 regulates neuronal receptors and channels 2.0 12.0 8.046153846153846 0.0333651833289618 0.0 0.0 0.0 0.0 |
| Mecp2 regulates transcription factors 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mecp2 regulates transcription of neuronal ligands 1.0 4.0 10.0 0.0941782060147337 0.0 0.0 0.0 0.0 |
| Meiosis 2.0 54.0 1.5407972594207413 0.3814690602891797 0.0 0.0 0.0 0.0 |
| Meiotic recombination 1.0 31.0 1.3329301075268818 0.5358758009484922 0.0 0.0 0.0 0.0 |
| Meiotic synapsis 1.0 31.0 1.3329301075268818 0.5358758009484922 0.0 0.0 0.0 0.0 |
| Membrane trafficking 10.0 532.0 0.7554625755462575 0.8439289106134099 0.0 0.0 0.0 0.0 |
| Met activates pi3k akt signaling 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met activates ptk2 signaling 1.0 19.0 2.2242383512544803 0.3751137360333714 0.0 0.0 0.0 0.0 |
| Met activates ptpn11 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met activates rap1 and rac1 1.0 11.0 4.006854838709677 0.2382253475836706 0.0 0.0 0.0 0.0 |
| Met activates ras signaling 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met interacts with tns proteins 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met promotes cell motility 2.0 29.0 2.9749587644324484 0.157217223036351 0.0 0.0 0.0 0.0 |
| Met receptor activation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met receptor recycling 1.0 10.0 4.452508960573477 0.2191369015278419 0.0 0.0 0.0 0.0 |
| Metabolic disorders of biological oxidation enzymes 1.0 13.0 3.3383736559139785 0.2750191284248381 0.0 0.0 0.0 0.0 |
| Metabolism of amine derived hormones 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of amino acids and derivatives 12.0 281.0 1.821655451508164 0.0429189147797386 0.0 0.0 0.0 0.0 |
| Metabolism of angiotensinogen to angiotensins 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of carbohydrates 10.0 201.0 2.1371771561260924 0.0256431656667684 0.0 0.0 0.0 0.0 |
| Metabolism of cofactors 2.0 15.0 6.187480535658674 0.0506052248933858 0.0 0.0 0.0 0.0 |
| Metabolism of fat soluble vitamins 1.0 29.0 1.4284274193548387 0.5122775749816724 0.0 0.0 0.0 0.0 |
| Metabolism of folate and pterines 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of ingested semet sec mesec into h2se 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of lipids 7.0 508.0 0.5453720657857838 0.9683446620324738 0.0 0.0 0.0 0.0 |
| Metabolism of nitric oxide nos3 activation and regulation 1.0 10.0 4.452508960573477 0.2191369015278419 0.0 0.0 0.0 0.0 |
| Metabolism of nucleotides 4.0 82.0 2.065724751439037 0.1403384967506907 0.0 0.0 0.0 0.0 |
| Metabolism of polyamines 1.0 48.0 0.8493479752916953 0.6956428968189323 0.0 0.0 0.0 0.0 |
| Metabolism of porphyrins 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of rna 38.0 647.0 2.7614533965244865 3.5116602535709694e-07 0.0 0.0 0.0 0.0 |
| Metabolism of steroid hormones 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of steroids 1.0 103.0 0.3891919671094244 0.9226649017160016 0.0 0.0 0.0 0.0 |
| Metabolism of vitamins and cofactors 3.0 134.0 0.9137963135356544 0.6399019805088986 0.0 0.0 0.0 0.0 |
| Metabolism of water soluble vitamins and cofactors 0.0 91.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metal ion slc transporters 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metalloprotease dubs 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metallothioneins bind metals 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Methionine salvage pathway 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Methylation 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mhc class ii antigen presentation 5.0 100.0 2.125107851596204 0.0977310673672498 0.0 0.0 0.0 0.0 |
| Microrna mirna biogenesis 1.0 24.0 1.7398316970546983 0.4479222530759854 0.0 0.0 0.0 0.0 |
| Miro gtpase cycle 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Miscellaneous substrates 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Miscellaneous transport and binding events 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mismatch repair 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial biogenesis 0.0 85.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial calcium ion transport 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial fatty acid beta oxidation 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial fatty acid beta oxidation of saturated fatty acids 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial fatty acid beta oxidation of unsaturated fatty acids 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial iron sulfur cluster biogenesis 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial protein import 0.0 59.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial translation 5.0 93.0 2.295780551415797 0.0770567400392524 0.0 0.0 0.0 0.0 |
| Mitochondrial trna aminoacylation 4.0 23.0 8.531041890440386 0.0021324559374895 0.0 0.0 0.0 0.0 |
| Mitochondrial uncoupling 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitophagy 1.0 24.0 1.7398316970546983 0.4479222530759854 0.0 0.0 0.0 0.0 |
| Mitotic g1 phase and g1 s transition 4.0 143.0 1.1520187931287622 0.4637293328283498 0.0 0.0 0.0 0.0 |
| Mitotic g2 g2 m phases 2.0 186.0 0.4296338672768878 0.9446074977704256 0.0 0.0 0.0 0.0 |
| Mitotic metaphase and anaphase 5.0 225.0 0.9060171385991058 0.6471481835072559 0.0 0.0 0.0 0.0 |
| Mitotic prometaphase 5.0 198.0 1.0356323791726834 0.533499139132107 0.0 0.0 0.0 0.0 |
| Mitotic prophase 4.0 93.0 1.8083925705113504 0.1922797282129693 0.0 0.0 0.0 0.0 |
| Mitotic spindle checkpoint 4.0 111.0 1.5014304787335495 0.2870904919279606 0.0 0.0 0.0 0.0 |
| Mitotic telophase cytokinesis 1.0 13.0 3.3383736559139785 0.2750191284248381 0.0 0.0 0.0 0.0 |
| Modulation by mtb of host immune system 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Molecules associated with elastic fibres 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Molybdenum cofactor biosynthesis 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mrna capping 1.0 29.0 1.4284274193548387 0.5122775749816724 0.0 0.0 0.0 0.0 |
| Mrna decay by 3 to 5 exoribonuclease 4.0 16.0 10.0 0.0005013179159177 0.0 0.0 0.0 0.0 |
| Mrna decay by 5 to 3 exoribonuclease 2.0 15.0 6.187480535658674 0.0506052248933858 0.0 0.0 0.0 0.0 |
| Mrna editing 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mrna editing c to u conversion 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mrna splicing 13.0 188.0 3.07593220338983 0.0006987298404783 0.0 0.0 0.0 0.0 |
| Mrna splicing minor pathway 3.0 52.0 2.463414634146341 0.1335053000482259 0.0 0.0 0.0 0.0 |
| Mtor signalling 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mtorc1 mediated signalling 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mucopolysaccharidoses 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Multifunctional anion exchangers 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Muscle contraction 3.0 83.0 1.5041158536585366 0.3307021173519288 0.0 0.0 0.0 0.0 |
| Myd88 independent tlr4 cascade 2.0 78.0 1.0516727040272746 0.5717749293752659 0.0 0.0 0.0 0.0 |
| Myoclonic epilepsy of lafora 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Myogenesis 1.0 22.0 1.905913978494624 0.4198721048864768 0.0 0.0 0.0 0.0 |
| N glycan antennae elongation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| N glycan antennae elongation in the medial trans golgi 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| N glycan trimming and elongation in the cis golgi 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| N glycan trimming in the er and calnexin calreticulin cycle 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Na cl dependent neurotransmitter transporters 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nade modulates death signalling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ncam signaling for neurite out growth 2.0 34.0 2.508856275303644 0.2012424218570439 0.0 0.0 0.0 0.0 |
| Ncam1 interactions 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nectin necl trans heterodimerization 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neddylation 1.0 185.0 0.2139507363253857 0.990111021813182 0.0 0.0 0.0 0.0 |
| Nef and signal transduction 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nef mediated cd4 down regulation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nef mediated cd8 down regulation 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nef mediated downregulation of mhc class i complex cell surface expression 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nef mediates down modulation of cell surface receptors by recruiting them to clathrin adapters 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative epigenetic regulation of rrna expression 3.0 61.0 2.0792682926829267 0.1865630132096767 0.0 0.0 0.0 0.0 |
| Negative feedback regulation of mapk pathway 1.0 6.0 8.01774193548387 0.1378997973237242 0.0 0.0 0.0 0.0 |
| Negative regulation of activity of tfap2 ap 2 family transcription factors 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of fgfr1 signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of fgfr2 signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of fgfr3 signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of fgfr4 signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of flt3 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of mapk pathway 2.0 36.0 2.3608001905215525 0.2192395028209926 0.0 0.0 0.0 0.0 |
| Negative regulation of met activity 1.0 20.0 2.1069609507640066 0.3904027877902372 0.0 0.0 0.0 0.0 |
| Negative regulation of nmda receptor mediated neuronal transmission 1.0 14.0 3.081265508684864 0.2927467368934597 0.0 0.0 0.0 0.0 |
| Negative regulation of notch4 signaling 0.0 49.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of tcf dependent signaling by dvl interacting proteins 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of tcf dependent signaling by wnt ligand antagonists 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of the pi3k akt network 1.0 62.0 0.6534902168164992 0.7850994570773475 0.0 0.0 0.0 0.0 |
| Negative regulators of ddx58 ifih1 signaling 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nephrin family interactions 2.0 17.0 5.36140350877193 0.0635022977163126 0.0 0.0 0.0 0.0 |
| Nervous system development 15.0 443.0 1.4256829618979152 0.1254415893732152 0.0 0.0 0.0 0.0 |
| Netrin 1 signaling 1.0 33.0 1.2493699596774193 0.558336601374079 0.0 0.0 0.0 0.0 |
| Netrin mediated repulsion signals 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neurexins and neuroligins 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neurofascin interactions 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neuronal system 3.0 177.0 0.6849593495934959 0.8115027398943269 0.0 0.0 0.0 0.0 |
| Neurotoxicity of clostridium toxins 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neurotransmitter clearance 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neurotransmitter receptors and postsynaptic signal transmission 1.0 105.0 0.3816299627791563 0.926433818068224 0.0 0.0 0.0 0.0 |
| Neurotransmitter release cycle 1.0 30.0 1.3790322580645162 0.5242223850322378 0.0 0.0 0.0 0.0 |
| Neutrophil degranulation 8.0 319.0 1.02851196114795 0.5205827542215604 0.0 0.0 0.0 0.0 |
| Nf kb activation through fadd rip 1 pathway mediated by caspase 8 and 10 1.0 13.0 3.3383736559139785 0.2750191284248381 0.0 0.0 0.0 0.0 |
| Nf kb is activated and signals survival 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ngf independant trka activation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ngf stimulated transcription 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nicotinamide salvaging 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nicotinate metabolism 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nitric oxide stimulates guanylate cyclase 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nod1 2 signaling pathway 1.0 30.0 1.3790322580645162 0.5242223850322378 0.0 0.0 0.0 0.0 |
| Non integrin membrane ecm interactions 1.0 37.0 1.1101030465949822 0.6000617657406979 0.0 0.0 0.0 0.0 |
| Noncanonical activation of notch3 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nonhomologous end joining nhej 2.0 41.0 2.057095401224956 0.2646794233181401 0.0 0.0 0.0 0.0 |
| Nonsense mediated decay nmd 5.0 110.0 1.9207650273224044 0.1315732933994563 0.0 0.0 0.0 0.0 |
| Norepinephrine neurotransmitter release cycle 1.0 12.0 3.642228739002933 0.256848998879423 0.0 0.0 0.0 0.0 |
| Nostrin mediated enos trafficking 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch hlh transcription pathway 1.0 21.0 2.0014112903225807 0.4053192290166058 0.0 0.0 0.0 0.0 |
| Notch1 intracellular domain regulates transcription 1.0 39.0 1.0514643463497453 0.6194276439258724 0.0 0.0 0.0 0.0 |
| Notch2 activation and transmission of signal to the nucleus 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch2 intracellular domain regulates transcription 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch3 activation and transmission of signal to the nucleus 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch3 intracellular domain regulates transcription 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch4 activation and transmission of signal to the nucleus 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch4 intracellular domain regulates transcription 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 and nr1h3 mediated signaling 1.0 31.0 1.3329301075268818 0.5358758009484922 0.0 0.0 0.0 0.0 |
| Nr1h2 nr1h3 regulate gene expression linked to gluconeogenesis 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 nr1h3 regulate gene expression linked to lipogenesis 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 nr1h3 regulate gene expression linked to triglyceride lipolysis in adipose 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 nr1h3 regulate gene expression to control bile acid homeostasis 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 nr1h3 regulate gene expression to limit cholesterol uptake 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h3 nr1h2 regulate gene expression linked to cholesterol transport and efflux 1.0 26.0 1.6003225806451613 0.4746213136734084 0.0 0.0 0.0 0.0 |
| Nrage signals death through jnk 0.0 47.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nrcam interactions 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nrif signals cell death from the nucleus 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ns1 mediated effects on host pathways 3.0 40.0 3.2663150955833884 0.0734338910721259 0.0 0.0 0.0 0.0 |
| Ntrk2 activates rac1 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nuclear envelope breakdown 2.0 54.0 1.5407972594207413 0.3814690602891797 0.0 0.0 0.0 0.0 |
| Nuclear envelope ne reassembly 2.0 71.0 1.159185589391539 0.5207614848352471 0.0 0.0 0.0 0.0 |
| Nuclear events kinase and transcription factor activation 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nuclear events stimulated by alk signaling in cancer 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nuclear import of rev protein 2.0 34.0 2.508856275303644 0.2012424218570439 0.0 0.0 0.0 0.0 |
| Nuclear pore complex npc disassembly 2.0 36.0 2.3608001905215525 0.2192395028209926 0.0 0.0 0.0 0.0 |
| Nuclear receptor transcription pathway 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nuclear signaling by erbb4 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nucleotide binding domain leucine rich repeat containing receptor nlr signaling pathways 1.0 42.0 0.9742328874901652 0.6467390349138054 0.0 0.0 0.0 0.0 |
| Nucleotide biosynthesis 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nucleotide catabolism 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nucleotide excision repair 2.0 114.0 0.7110323886639676 0.7716810988666172 0.0 0.0 0.0 0.0 |
| Nucleotide like purinergic receptors 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nucleotide salvage 1.0 20.0 2.1069609507640066 0.3904027877902372 0.0 0.0 0.0 0.0 |
| O glycosylation of tsr domain containing proteins 2.0 5.0 10.0 0.0056579443580751 0.0 0.0 0.0 0.0 |
| O linked glycosylation 2.0 35.0 2.4325849589007484 0.2102212619820596 0.0 0.0 0.0 0.0 |
| O linked glycosylation of mucins 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Oas antiviral response 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Olfactory signaling pathway 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Oncogene induced senescence 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Oncogenic mapk signaling 2.0 66.0 1.2503795546558705 0.4819291496478894 0.0 0.0 0.0 0.0 |
| Opioid signalling 0.0 63.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Orc1 removal from chromatin 1.0 65.0 0.6226688508064516 0.8005557157271664 0.0 0.0 0.0 0.0 |
| Organelle biogenesis and maintenance 3.0 268.0 0.4455591348366314 0.9618625893717804 0.0 0.0 0.0 0.0 |
| Organic anion transporters 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Organic cation anion zwitterion transport 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Organic cation transport 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Other interleukin signaling 1.0 12.0 3.642228739002933 0.256848998879423 0.0 0.0 0.0 0.0 |
| Other semaphorin interactions 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ovarian tumor domain proteases 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Oxidative stress induced senescence 1.0 69.0 0.5858040796963947 0.8194550900233434 0.0 0.0 0.0 0.0 |
| P130cas linkage to mapk signaling for integrins 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P2y receptors 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P38mapk events 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P75 ntr receptor mediated signalling 1.0 81.0 0.497328629032258 0.8661025244336329 0.0 0.0 0.0 0.0 |
| P75ntr negatively regulates cell cycle via sc1 1.0 5.0 10.0 0.1163082714273898 0.0 0.0 0.0 0.0 |
| P75ntr recruits signalling complexes 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P75ntr regulates axonogenesis 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P75ntr signals via nf kb 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Parasite infection 1.0 50.0 0.8145161290322581 0.7103963062821104 0.0 0.0 0.0 0.0 |
| Passive transport by aquaporins 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pcna dependent long patch base excision repair 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pcp ce pathway 0.0 78.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pd 1 signaling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pecam1 interactions 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pentose phosphate pathway 1.0 13.0 3.3383736559139785 0.2750191284248381 0.0 0.0 0.0 0.0 |
| Peptide hormone metabolism 0.0 43.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Peptide ligand binding receptors 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Perk regulates gene expression 3.0 26.0 5.261930010604454 0.0247234076565489 0.0 0.0 0.0 0.0 |
| Peroxisomal lipid metabolism 2.0 24.0 3.652926021347074 0.1154739846724814 0.0 0.0 0.0 0.0 |
| Peroxisomal protein import 5.0 51.0 4.410637918745545 0.0078507588763973 0.0 0.0 0.0 0.0 |
| Pexophagy 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase 0 rapid depolarisation 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase 2 plateau phase 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase 3 rapid repolarisation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase 4 resting membrane potential 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase i functionalization of compounds 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase ii conjugation of compounds 3.0 53.0 2.4139024390243904 0.1391149976670843 0.0 0.0 0.0 0.0 |
| Phenylalanine and tyrosine metabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phenylalanine metabolism 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phosphate bond hydrolysis by ntpdase proteins 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phosphate bond hydrolysis by nudt proteins 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phospholipase c mediated cascade fgfr2 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phospholipase c mediated cascade fgfr4 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phospholipid metabolism 2.0 156.0 0.5149061464850938 0.8981458903296828 0.0 0.0 0.0 0.0 |
| Phosphorylation of emi1 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phosphorylation of the apc c 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Physiological factors 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi 3k cascade fgfr1 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi 3k cascade fgfr2 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi 3k cascade fgfr3 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi 3k cascade fgfr4 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi metabolism 2.0 71.0 1.159185589391539 0.5207614848352471 0.0 0.0 0.0 0.0 |
| Pi3k akt activation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi3k akt signaling in cancer 2.0 58.0 1.430161943319838 0.4159834663932839 0.0 0.0 0.0 0.0 |
| Pi3k events in erbb2 signaling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi3k events in erbb4 signaling 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi5p regulates tp53 acetylation 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pink1 prkn mediated mitophagy 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Piwi interacting rna pirna biogenesis 1.0 16.0 2.66989247311828 0.3269170707962712 0.0 0.0 0.0 0.0 |
| Pka activation in glucagon signalling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pka mediated phosphorylation of creb 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pka mediated phosphorylation of key metabolic factors 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pkmts methylate histone lysines 1.0 46.0 0.8872759856630824 0.6801410689133394 0.0 0.0 0.0 0.0 |
| Plasma lipoprotein assembly 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Plasma lipoprotein assembly remodeling and clearance 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Plasma lipoprotein clearance 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Plasma lipoprotein remodeling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Platelet activation signaling and aggregation 4.0 152.0 1.0809707666850523 0.511280975736922 0.0 0.0 0.0 0.0 |
| Platelet adhesion to exposed collagen 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Platelet aggregation plug formation 1.0 20.0 2.1069609507640066 0.3904027877902372 0.0 0.0 0.0 0.0 |
| Platelet calcium homeostasis 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Platelet homeostasis 1.0 51.0 0.7981451612903225 0.7175036707273205 0.0 0.0 0.0 0.0 |
| Platelet sensitization by ldl 1.0 15.0 2.860887096774193 0.3100425591757577 0.0 0.0 0.0 0.0 |
| Polb dependent long patch base excision repair 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Polo like kinase mediated events 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Polymerase switching 1.0 16.0 2.66989247311828 0.3269170707962712 0.0 0.0 0.0 0.0 |
| Polymerase switching on the c strand of the telomere 2.0 28.0 3.0896916848333853 0.1486468007453543 0.0 0.0 0.0 0.0 |
| Positive epigenetic regulation of rrna expression 3.0 60.0 2.1159606332905434 0.1804107268936248 0.0 0.0 0.0 0.0 |
| Post chaperonin tubulin folding pathway 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Post translational modification synthesis of gpi anchored proteins 1.0 32.0 1.289802289281998 0.5472449033122827 0.0 0.0 0.0 0.0 |
| Post translational protein modification 22.0 1003.0 0.8857813882265242 0.7352735452381036 0.0 0.0 0.0 0.0 |
| Postmitotic nuclear pore complex npc reformation 1.0 27.0 1.5386166253101736 0.487484567646441 0.0 0.0 0.0 0.0 |
| Potassium channels 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Potential therapeutics for sars 2.0 68.0 1.2122438964544229 0.4976941658352568 0.0 0.0 0.0 0.0 |
| Pou5f1 oct4 sox2 nanog activate genes related to proliferation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pou5f1 oct4 sox2 nanog repress genes related to differentiation 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pp2a mediated dephosphorylation of key metabolic factors 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Prc2 methylates histones and dna 1.0 23.0 1.819098240469208 0.4340702418800846 0.0 0.0 0.0 0.0 |
| Pre notch expression and processing 0.0 50.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pre notch processing in golgi 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pre notch processing in the endoplasmic reticulum 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pregnenolone biosynthesis 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Presynaptic depolarization and calcium channel opening 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Presynaptic function of kainate receptors 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Presynaptic nicotinic acetylcholine receptors 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Prevention of phagosomal lysosomal fusion 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processing and activation of sumo 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processing of capped intron containing pre mrna 16.0 239.0 2.9943609384322256 0.0002498160429616 0.0 0.0 0.0 0.0 |
| Processing of capped intronless pre mrna 3.0 29.0 4.653377110694184 0.0329460998536745 0.0 0.0 0.0 0.0 |
| Processing of dna double strand break ends 0.0 66.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processing of intronless pre mrnas 3.0 21.0 6.726964769647696 0.0138257504316944 0.0 0.0 0.0 0.0 |
| Processing of smdt1 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processive synthesis on the c strand of the telomere 1.0 21.0 2.0014112903225807 0.4053192290166058 0.0 0.0 0.0 0.0 |
| Processive synthesis on the lagging strand 1.0 17.0 2.502772177419355 0.3433804941091314 0.0 0.0 0.0 0.0 |
| Programmed cell death 2.0 179.0 0.4469452640728287 0.936022146711764 0.0 0.0 0.0 0.0 |
| Prolactin receptor signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Prolonged erk activation events 2.0 12.0 8.046153846153846 0.0333651833289618 0.0 0.0 0.0 0.0 |
| Propionyl coa catabolism 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Prostacyclin signalling through prostacyclin receptor 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Protein folding 1.0 79.0 0.5101840363937138 0.8592596292484254 0.0 0.0 0.0 0.0 |
| Protein localization 5.0 142.0 1.4673327749192293 0.2664943358432097 0.0 0.0 0.0 0.0 |
| Protein methylation 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Protein protein interactions at synapses 1.0 46.0 0.8872759856630824 0.6801410689133394 0.0 0.0 0.0 0.0 |
| Protein repair 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Protein ubiquitination 2.0 58.0 1.430161943319838 0.4159834663932839 0.0 0.0 0.0 0.0 |
| Proton coupled monocarboxylate transport 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pten regulation 3.0 128.0 0.9582439024390244 0.6089215114543709 0.0 0.0 0.0 0.0 |
| Ptk6 expression 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ptk6 promotes hif1a stabilization 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ptk6 regulates cell cycle 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ptk6 regulates proteins involved in rna processing 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ptk6 regulates rho gtpases ras gtpase and map kinases 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ptk6 regulates rtks and their effectors akt1 and dok1 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Purine catabolism 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Purine ribonucleoside monophosphate biosynthesis 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Purine salvage 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Purinergic signaling in leishmaniasis infection 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pyrimidine catabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pyrimidine salvage 1.0 9.0 5.009576612903226 0.1995721086637891 0.0 0.0 0.0 0.0 |
| Pyroptosis 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pyruvate metabolism 1.0 26.0 1.6003225806451613 0.4746213136734084 0.0 0.0 0.0 0.0 |
| Pyruvate metabolism and citric acid tca cycle 3.0 48.0 2.683468834688347 0.1119144158382109 0.0 0.0 0.0 0.0 |
| Ra biosynthesis pathway 1.0 9.0 5.009576612903226 0.1995721086637891 0.0 0.0 0.0 0.0 |
| Rab gefs exchange gtp for gdp on rabs 1.0 79.0 0.5101840363937138 0.8592596292484254 0.0 0.0 0.0 0.0 |
| Rab geranylgeranylation 1.0 54.0 0.7527388922702374 0.7378001234946985 0.0 0.0 0.0 0.0 |
| Rab regulation of trafficking 2.0 107.0 0.7589743589743589 0.7405589746065433 0.0 0.0 0.0 0.0 |
| Rac1 gtpase cycle 1.0 152.0 0.2615894039735099 0.9773270639252796 0.0 0.0 0.0 0.0 |
| Rac2 gtpase cycle 0.0 81.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rac3 gtpase cycle 0.0 83.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Raf activation 2.0 33.0 2.5900483217970485 0.1923105654227066 0.0 0.0 0.0 0.0 |
| Raf independent mapk1 3 activation 1.0 15.0 2.860887096774193 0.3100425591757577 0.0 0.0 0.0 0.0 |
| Rap1 signalling 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ras activation upon ca2 influx through nmda receptor 1.0 13.0 3.3383736559139785 0.2750191284248381 0.0 0.0 0.0 0.0 |
| Ras processing 1.0 19.0 2.2242383512544803 0.3751137360333714 0.0 0.0 0.0 0.0 |
| Ras signaling downstream of nf1 loss of function variants 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Reactions specific to the complex n glycan synthesis pathway 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Receptor mediated mitophagy 1.0 10.0 4.452508960573477 0.2191369015278419 0.0 0.0 0.0 0.0 |
| Receptor type tyrosine protein phosphatases 1.0 11.0 4.006854838709677 0.2382253475836706 0.0 0.0 0.0 0.0 |
| Recognition and association of dna glycosylase with site containing an affected purine 1.0 16.0 2.66989247311828 0.3269170707962712 0.0 0.0 0.0 0.0 |
| Recognition of dna damage by pcna containing replication complex 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Recruitment of mitotic centrosome proteins and complexes 1.0 82.0 0.4911389884508164 0.8693986659534523 0.0 0.0 0.0 0.0 |
| Recruitment of numa to mitotic centrosomes 1.0 90.0 0.446629213483146 0.8930180836943507 0.0 0.0 0.0 0.0 |
| Recycling of bile acids and salts 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Recycling of eif2 gdp 1.0 8.0 5.725806451612903 0.1795191310032965 0.0 0.0 0.0 0.0 |
| Recycling pathway of l1 3.0 41.0 3.180038510911425 0.0778634639331788 0.0 0.0 0.0 0.0 |
| Reduction of cytosolic ca levels 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Reelin signalling pathway 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulated necrosis 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulated proteolysis of p75ntr 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation by c flip 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of bach1 activity 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of beta cell development 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of cholesterol biosynthesis by srebp srebf 0.0 55.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of commissural axon pathfinding by slit and robo 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of cytoskeletal remodeling and cell spreading by ipp complex components 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of expression of slits and robos 6.0 155.0 1.6236639323887645 0.1786437467168821 0.0 0.0 0.0 0.0 |
| Regulation of foxo transcriptional activity by acetylation 2.0 10.0 10.0 0.0234889728544392 0.0 0.0 0.0 0.0 |
| Regulation of fzd by ubiquitination 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of gene expression by hypoxia inducible factor 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of gene expression in beta cells 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of gene expression in early pancreatic precursor cells 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of gene expression in late stage branching morphogenesis pancreatic bud precursor cells 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of glucokinase by glucokinase regulatory protein 2.0 31.0 2.769230769230769 0.1746199077901094 0.0 0.0 0.0 0.0 |
| Regulation of glycolysis by fructose 2 6 bisphosphate metabolism 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of hmox1 expression and activity 0.0 58.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of hsf1 mediated heat shock response 5.0 76.0 2.850380974370815 0.0379484136991646 0.0 0.0 0.0 0.0 |
| Regulation of ifna signaling 1.0 8.0 5.725806451612903 0.1795191310032965 0.0 0.0 0.0 0.0 |
| Regulation of ifng signaling 1.0 10.0 4.452508960573477 0.2191369015278419 0.0 0.0 0.0 0.0 |
| Regulation of innate immune responses to cytosolic dna 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of insulin like growth factor igf transport and uptake by insulin like growth factor binding proteins igfbps 2.0 56.0 1.4834307992202729 0.3988408250989342 0.0 0.0 0.0 0.0 |
| Regulation of insulin secretion 0.0 48.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of kit signaling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of lipid metabolism by pparalpha 1.0 95.0 0.4226578586135895 0.905566338908512 0.0 0.0 0.0 0.0 |
| Regulation of localization of foxo transcription factors 1.0 13.0 3.3383736559139785 0.2750191284248381 0.0 0.0 0.0 0.0 |
| Regulation of mecp2 expression and activity 1.0 30.0 1.3790322580645162 0.5242223850322378 0.0 0.0 0.0 0.0 |
| Regulation of mrna stability by proteins that bind au rich elements 5.0 79.0 2.733994240141781 0.0436920542131148 0.0 0.0 0.0 0.0 |
| Regulation of plk1 activity at g2 m transition 0.0 87.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of pten gene transcription 3.0 56.0 2.276576161988035 0.1564032996109324 0.0 0.0 0.0 0.0 |
| Regulation of pten localization 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of pten mrna translation 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of pten stability and activity 0.0 63.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of pyruvate dehydrogenase pdh complex 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of ras by gaps 0.0 57.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of runx1 expression and activity 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of runx2 expression and activity 0.0 61.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of runx3 expression and activity 0.0 52.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of signaling by cbl 1.0 18.0 2.355313092979128 0.3594428044513148 0.0 0.0 0.0 0.0 |
| Regulation of signaling by nodal 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tlr by endogenous ligand 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tnfr1 signaling 1.0 31.0 1.3329301075268818 0.5358758009484922 0.0 0.0 0.0 0.0 |
| Regulation of tp53 activity 2.0 146.0 0.551225820962663 0.8758885815065437 0.0 0.0 0.0 0.0 |
| Regulation of tp53 activity through acetylation 1.0 30.0 1.3790322580645162 0.5242223850322378 0.0 0.0 0.0 0.0 |
| Regulation of tp53 activity through association with co factors 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tp53 activity through methylation 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tp53 activity through phosphorylation 0.0 82.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tp53 expression and degradation 1.0 33.0 1.2493699596774193 0.558336601374079 0.0 0.0 0.0 0.0 |
| Release of apoptotic factors from the mitochondria 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Release of hh np from the secreting cell 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Removal of aminoterminal propeptides from gamma carboxylated proteins 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Repression of wnt target genes 2.0 13.0 7.313949208686051 0.0388074443523606 0.0 0.0 0.0 0.0 |
| Reproduction 2.0 57.0 1.456312108943688 0.4074419886033491 0.0 0.0 0.0 0.0 |
| Resolution of abasic sites ap sites 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Resolution of ap sites via the multiple nucleotide patch replacement pathway 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Resolution of d loop structures 1.0 32.0 1.289802289281998 0.5472449033122827 0.0 0.0 0.0 0.0 |
| Resolution of d loop structures through synthesis dependent strand annealing sdsa 1.0 26.0 1.6003225806451613 0.4746213136734084 0.0 0.0 0.0 0.0 |
| Resolution of sister chromatid cohesion 4.0 120.0 1.383673469387755 0.3368812136284692 0.0 0.0 0.0 0.0 |
| Respiratory electron transport 5.0 101.0 2.102757855191257 0.1008932065693596 0.0 0.0 0.0 0.0 |
| Respiratory electron transport atp synthesis by chemiosmotic coupling and heat production by uncoupling proteins 5.0 116.0 1.8158322256682915 0.1540990039001299 0.0 0.0 0.0 0.0 |
| Response of eif2ak1 hri to heme deficiency 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Response of eif2ak4 gcn2 to amino acid deficiency 4.0 94.0 1.7881179138321996 0.1972765639959978 0.0 0.0 0.0 0.0 |
| Response of mtb to phagocytosis 1.0 20.0 2.1069609507640066 0.3904027877902372 0.0 0.0 0.0 0.0 |
| Response to elevated platelet cytosolic ca2 3.0 71.0 1.771700143472023 0.2505872457528773 0.0 0.0 0.0 0.0 |
| Response to metal ions 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ret signaling 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Retinoid cycle disease events 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Retrograde neurotrophin signalling 1.0 12.0 3.642228739002933 0.256848998879423 0.0 0.0 0.0 0.0 |
| Retrograde transport at the trans golgi network 0.0 49.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Reversible hydration of carbon dioxide 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpase cycle 8.0 387.0 0.8380209986971612 0.7343862877717828 0.0 0.0 0.0 0.0 |
| Rho gtpase effectors 6.0 246.0 0.9986625514403292 0.5595023155708374 0.0 0.0 0.0 0.0 |
| Rho gtpases activate cit 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate formins 4.0 133.0 1.2425881980699256 0.4091593155419392 0.0 0.0 0.0 0.0 |
| Rho gtpases activate iqgaps 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate ktn1 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate nadph oxidases 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate paks 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate pkns 1.0 40.0 1.0244003308519438 0.6287574181217924 0.0 0.0 0.0 0.0 |
| Rho gtpases activate rhotekin and rhophilins 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate rocks 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate wasps and waves 1.0 33.0 1.2493699596774193 0.558336601374079 0.0 0.0 0.0 0.0 |
| Rhoa gtpase cycle 2.0 134.0 0.60207336523126 0.8433258430076459 0.0 0.0 0.0 0.0 |
| Rhob gtpase cycle 1.0 69.0 0.5858040796963947 0.8194550900233434 0.0 0.0 0.0 0.0 |
| Rhobtb gtpase cycle 1.0 33.0 1.2493699596774193 0.558336601374079 0.0 0.0 0.0 0.0 |
| Rhobtb1 gtpase cycle 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhobtb2 gtpase cycle 1.0 22.0 1.905913978494624 0.4198721048864768 0.0 0.0 0.0 0.0 |
| Rhobtb3 atpase cycle 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhoc gtpase cycle 1.0 75.0 0.5379795117698344 0.8445114910553251 0.0 0.0 0.0 0.0 |
| Rhod gtpase cycle 1.0 50.0 0.8145161290322581 0.7103963062821104 0.0 0.0 0.0 0.0 |
| Rhof gtpase cycle 1.0 42.0 0.9742328874901652 0.6467390349138054 0.0 0.0 0.0 0.0 |
| Rhog gtpase cycle 1.0 71.0 0.5689516129032258 0.8282247490814505 0.0 0.0 0.0 0.0 |
| Rhoh gtpase cycle 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhoj gtpase cycle 0.0 55.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhoq gtpase cycle 0.0 59.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhot1 gtpase cycle 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhou gtpase cycle 1.0 39.0 1.0514643463497453 0.6194276439258724 0.0 0.0 0.0 0.0 |
| Rhov gtpase cycle 1.0 35.0 1.1756404174573054 0.5797145893212095 0.0 0.0 0.0 0.0 |
| Rip mediated nfkb activation via zbp1 1.0 16.0 2.66989247311828 0.3269170707962712 0.0 0.0 0.0 0.0 |
| Ripk1 mediated regulated necrosis 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rmts methylate histone arginines 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase i promoter escape 2.0 42.0 2.0054655870445344 0.2737930251240831 0.0 0.0 0.0 0.0 |
| Rna polymerase i transcription 3.0 63.0 2.0095528455284555 0.199027105147879 0.0 0.0 0.0 0.0 |
| Rna polymerase i transcription initiation 2.0 49.0 1.705573262124214 0.3371805301273846 0.0 0.0 0.0 0.0 |
| Rna polymerase i transcription termination 1.0 32.0 1.289802289281998 0.5472449033122827 0.0 0.0 0.0 0.0 |
| Rna polymerase ii transcribes snrna genes 7.0 73.0 4.330515902829952 0.0019675889741868 0.0 0.0 0.0 0.0 |
| Rna polymerase ii transcription 26.0 969.0 1.11324890983361 0.335415459393396 0.0 0.0 0.0 0.0 |
| Rna polymerase ii transcription termination 3.0 66.0 1.913279132791328 0.2180781108238514 0.0 0.0 0.0 0.0 |
| Rna polymerase iii chain elongation 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase iii transcription 2.0 44.0 1.909581646423752 0.2920005997725598 0.0 0.0 0.0 0.0 |
| Rna polymerase iii transcription initiation from type 1 promoter 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase iii transcription initiation from type 3 promoter 1.0 30.0 1.3790322580645162 0.5242223850322378 0.0 0.0 0.0 0.0 |
| Rna polymerase iii transcription termination 1.0 24.0 1.7398316970546983 0.4479222530759854 0.0 0.0 0.0 0.0 |
| Rnd1 gtpase cycle 1.0 36.0 1.1419354838709677 0.5900138775011101 0.0 0.0 0.0 0.0 |
| Rnd2 gtpase cycle 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rnd3 gtpase cycle 1.0 39.0 1.0514643463497453 0.6194276439258724 0.0 0.0 0.0 0.0 |
| Robo receptors bind akap5 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Role of abl in robo slit signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Role of lat2 ntal lab on calcium mobilization 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Role of phospholipids in phagocytosis 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Role of second messengers in netrin 1 signaling 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rora activates gene expression 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ros and rns production in phagocytes 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rrna modification in the mitochondrion 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rrna modification in the nucleus and cytosol 2.0 63.0 1.3122718523926462 0.4577228455319406 0.0 0.0 0.0 0.0 |
| Rrna processing 12.0 202.0 2.600133244503664 0.0039665912482574 0.0 0.0 0.0 0.0 |
| Rrna processing in the mitochondrion 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rsk activation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 and foxp3 control the development of regulatory t lymphocytes tregs 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 interacts with co factors whose precise effect on runx1 targets is not known 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates estrogen receptor mediated transcription 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates expression of components of tight junctions 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates genes involved in megakaryocyte differentiation and platelet function 1.0 39.0 1.0514643463497453 0.6194276439258724 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in bcr signaling 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in differentiation of hscs 0.0 68.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in differentiation of keratinocytes 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in differentiation of myeloid cells 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in interleukin signaling 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in wnt signaling 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx2 regulates bone development 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx2 regulates chondrocyte maturation 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx2 regulates genes involved in cell migration 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx2 regulates osteoblast differentiation 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates bcl2l11 bim transcription 1.0 5.0 10.0 0.1163082714273898 0.0 0.0 0.0 0.0 |
| Runx3 regulates cdkn1a transcription 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates immune response and cell migration 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates notch signaling 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates p14 arf 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates wnt signaling 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates yap1 mediated transcription 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| S phase 2.0 158.0 0.5082009758123118 0.9021277801867176 0.0 0.0 0.0 0.0 |
| Sars cov 1 infection 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sars cov 2 infection 0.0 62.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sars cov infections 2.0 128.0 0.6311291048133153 0.824299046233582 0.0 0.0 0.0 0.0 |
| Scavenging by class a receptors 1.0 10.0 4.452508960573477 0.2191369015278419 0.0 0.0 0.0 0.0 |
| Scavenging by class b receptors 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Scavenging by class f receptors 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Scavenging of heme from plasma 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Scf skp2 mediated degradation of p27 p21 0.0 54.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sealing of the nuclear envelope ne by escrt iii 1.0 26.0 1.6003225806451613 0.4746213136734084 0.0 0.0 0.0 0.0 |
| Selective autophagy 1.0 67.0 0.603677908113392 0.8102396018793399 0.0 0.0 0.0 0.0 |
| Selenoamino acid metabolism 5.0 107.0 1.9778608164577307 0.120914516329306 0.0 0.0 0.0 0.0 |
| Sema3a pak dependent axon repulsion 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sema3a plexin repulsion signaling by inhibiting integrin adhesion 1.0 10.0 4.452508960573477 0.2191369015278419 0.0 0.0 0.0 0.0 |
| Sema4d in semaphorin signaling 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sema4d induced cell migration and growth cone collapse 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sema4d mediated inhibition of cell attachment and migration 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Semaphorin interactions 1.0 48.0 0.8493479752916953 0.6956428968189323 0.0 0.0 0.0 0.0 |
| Senescence associated secretory phenotype sasp 0.0 54.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sensing of dna double strand breaks 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sensory perception 5.0 84.0 2.5596596804316247 0.0543659249851089 0.0 0.0 0.0 0.0 |
| Sensory perception of taste 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sensory processing of sound 4.0 40.0 4.494784580498866 0.0159331781494728 0.0 0.0 0.0 0.0 |
| Sensory processing of sound by outer hair cells of the cochlea 3.0 25.0 5.501662971175167 0.0222629680099487 0.0 0.0 0.0 0.0 |
| Separation of sister chromatids 4.0 179.0 0.9116734693877552 0.6406548165576882 0.0 0.0 0.0 0.0 |
| Serine biosynthesis 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Serotonin neurotransmitter release cycle 1.0 14.0 3.081265508684864 0.2927467368934597 0.0 0.0 0.0 0.0 |
| Shc mediated cascade fgfr1 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc mediated cascade fgfr3 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc mediated cascade fgfr4 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc related events triggered by igf1r 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc1 events in egfr signaling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc1 events in erbb2 signaling 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc1 events in erbb4 signaling 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sialic acid metabolism 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signal amplification 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signal attenuation 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signal regulatory protein family interactions 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signal transduction by l1 1.0 20.0 2.1069609507640066 0.3904027877902372 0.0 0.0 0.0 0.0 |
| Signaling by activin 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by alk 1.0 19.0 2.2242383512544803 0.3751137360333714 0.0 0.0 0.0 0.0 |
| Signaling by alk in cancer 1.0 52.0 0.782416192283365 0.7244372918180408 0.0 0.0 0.0 0.0 |
| Signaling by bmp 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by braf and raf1 fusions 2.0 53.0 1.5711677383504008 0.3727036615711079 0.0 0.0 0.0 0.0 |
| Signaling by csf3 g csf 1.0 22.0 1.905913978494624 0.4198721048864768 0.0 0.0 0.0 0.0 |
| Signaling by ctnnb1 phospho site mutants 1.0 15.0 2.860887096774193 0.3100425591757577 0.0 0.0 0.0 0.0 |
| Signaling by cytosolic fgfr1 fusion mutants 1.0 18.0 2.355313092979128 0.3594428044513148 0.0 0.0 0.0 0.0 |
| Signaling by egfr 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by egfr in cancer 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by erbb2 1.0 37.0 1.1101030465949822 0.6000617657406979 0.0 0.0 0.0 0.0 |
| Signaling by erbb2 ecd mutants 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by erbb2 in cancer 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by erbb4 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by erythropoietin 1.0 19.0 2.2242383512544803 0.3751137360333714 0.0 0.0 0.0 0.0 |
| Signaling by fgfr 1.0 57.0 0.7121975806451613 0.7566437763344733 0.0 0.0 0.0 0.0 |
| Signaling by fgfr in disease 2.0 48.0 1.74282696708326 0.3282008667998757 0.0 0.0 0.0 0.0 |
| Signaling by fgfr1 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr1 in disease 1.0 29.0 1.4284274193548387 0.5122775749816724 0.0 0.0 0.0 0.0 |
| Signaling by fgfr2 1.0 51.0 0.7981451612903225 0.7175036707273205 0.0 0.0 0.0 0.0 |
| Signaling by fgfr2 iiia tm 1.0 18.0 2.355313092979128 0.3594428044513148 0.0 0.0 0.0 0.0 |
| Signaling by fgfr2 in disease 1.0 28.0 1.4814814814814814 0.5000341145668529 0.0 0.0 0.0 0.0 |
| Signaling by fgfr3 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr3 fusions in cancer 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr4 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr4 in disease 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by flt3 fusion proteins 1.0 16.0 2.66989247311828 0.3269170707962712 0.0 0.0 0.0 0.0 |
| Signaling by flt3 itd and tkd mutants 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by gpcr 1.0 204.0 0.1935483870967742 0.993874698612774 0.0 0.0 0.0 0.0 |
| Signaling by hedgehog 0.0 122.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by hippo 1.0 21.0 2.0014112903225807 0.4053192290166058 0.0 0.0 0.0 0.0 |
| Signaling by insulin receptor 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by interleukins 9.0 248.0 1.5232217573221758 0.1535453791594572 0.0 0.0 0.0 0.0 |
| Signaling by kit in disease 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by leptin 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by lrp5 mutants 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by mapk mutants 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by membrane tethered fusions of pdgfra or pdgfrb 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by met 3.0 64.0 1.9764094362255096 0.2053330212528871 0.0 0.0 0.0 0.0 |
| Signaling by moderate kinase activity braf mutants 1.0 36.0 1.1419354838709677 0.5900138775011101 0.0 0.0 0.0 0.0 |
| Signaling by mras complex mutants 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by mst1 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by nodal 1.0 12.0 3.642228739002933 0.256848998879423 0.0 0.0 0.0 0.0 |
| Signaling by notch 1.0 152.0 0.2615894039735099 0.9773270639252796 0.0 0.0 0.0 0.0 |
| Signaling by notch1 1.0 56.0 0.7252199413489736 0.7505174291608054 0.0 0.0 0.0 0.0 |
| Signaling by notch1 hd domain mutants in cancer 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch1 pest domain mutants in cancer 1.0 45.0 0.907532991202346 0.6720977570778652 0.0 0.0 0.0 0.0 |
| Signaling by notch1 t 7 9 notch1 m1580 k2555 translocation mutant 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch2 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch3 0.0 35.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch4 0.0 71.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by ntrk2 trkb 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by ntrk3 trkc 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by ntrks 3.0 102.0 1.2131066765213108 0.4560381544938071 0.0 0.0 0.0 0.0 |
| Signaling by nuclear receptors 9.0 178.0 2.169674556213018 0.0304844038315742 0.0 0.0 0.0 0.0 |
| Signaling by pdgf 1.0 35.0 1.1756404174573054 0.5797145893212095 0.0 0.0 0.0 0.0 |
| Signaling by pdgfr in disease 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by pdgfra transmembrane juxtamembrane and kinase domain mutants 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by ptk6 1.0 36.0 1.1419354838709677 0.5900138775011101 0.0 0.0 0.0 0.0 |
| Signaling by receptor tyrosine kinases 9.0 344.0 1.0759701492537312 0.4648186206972812 0.0 0.0 0.0 0.0 |
| Signaling by retinoic acid 1.0 26.0 1.6003225806451613 0.4746213136734084 0.0 0.0 0.0 0.0 |
| Signaling by rho gtpases miro gtpases and rhobtb3 14.0 593.0 0.9638922573769888 0.5920154568519175 0.0 0.0 0.0 0.0 |
| Signaling by rnf43 mutants 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by robo receptors 6.0 197.0 1.261198371146015 0.3501210742293589 0.0 0.0 0.0 0.0 |
| Signaling by scf kit 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by tgf beta receptor complex 4.0 67.0 2.561451247165533 0.0808304233724746 0.0 0.0 0.0 0.0 |
| Signaling by tgf beta receptor complex in cancer 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by tgfb family members 4.0 79.0 2.149006802721088 0.1272831365513204 0.0 0.0 0.0 0.0 |
| Signaling by the b cell receptor bcr 2.0 91.0 0.8968748578446982 0.6557862665479359 0.0 0.0 0.0 0.0 |
| Signaling by type 1 insulin like growth factor 1 receptor igf1r 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by vegf 1.0 87.0 0.4623499624906226 0.8847057966010409 0.0 0.0 0.0 0.0 |
| Signaling by wnt 4.0 213.0 0.7607069622107216 0.7686538652202597 0.0 0.0 0.0 0.0 |
| Signaling by wnt in cancer 2.0 25.0 3.493751100158423 0.123579290468326 0.0 0.0 0.0 0.0 |
| Signalling to erks 2.0 30.0 2.8684210526315788 0.1658780833937837 0.0 0.0 0.0 0.0 |
| Signalling to p38 via rit and rin 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signalling to ras 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sirt1 negatively regulates rrna expression 1.0 18.0 2.355313092979128 0.3594428044513148 0.0 0.0 0.0 0.0 |
| Slbp dependent processing of replication dependent histone pre mrnas 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Slc mediated transmembrane transport 1.0 101.0 0.3970564516129032 0.9187037124824016 0.0 0.0 0.0 0.0 |
| Slc transporter disorders 2.0 54.0 1.5407972594207413 0.3814690602891797 0.0 0.0 0.0 0.0 |
| Smac xiap regulated apoptotic response 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Smad2 smad3 smad4 heterotrimer regulates transcription 2.0 29.0 2.9749587644324484 0.157217223036351 0.0 0.0 0.0 0.0 |
| Small interfering rna sirna biogenesis 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Smooth muscle contraction 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Snrnp assembly 3.0 53.0 2.4139024390243904 0.1391149976670843 0.0 0.0 0.0 0.0 |
| Sodium calcium exchangers 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sodium coupled phosphate cotransporters 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sodium proton exchangers 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sos mediated signalling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sperm motility and taxes 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sphingolipid de novo biosynthesis 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sphingolipid metabolism 0.0 62.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Spry regulation of fgf signaling 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Srp dependent cotranslational protein targeting to membrane 4.0 108.0 1.545211930926217 0.2707233824490334 0.0 0.0 0.0 0.0 |
| Stabilization of p53 0.0 51.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Stat3 nuclear events downstream of alk signaling 1.0 6.0 8.01774193548387 0.1378997973237242 0.0 0.0 0.0 0.0 |
| Stat5 activation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Stat5 activation downstream of flt3 itd mutants 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Stimuli sensing channels 0.0 38.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sting mediated induction of host immune responses 1.0 10.0 4.452508960573477 0.2191369015278419 0.0 0.0 0.0 0.0 |
| Striated muscle contraction 3.0 16.0 9.318949343339588 0.0063676045893722 0.0 0.0 0.0 0.0 |
| Sulfide oxidation to sulfate 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sulfur amino acid metabolism 1.0 22.0 1.905913978494624 0.4198721048864768 0.0 0.0 0.0 0.0 |
| Sumo is conjugated to e1 uba2 sae1 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumo is proteolytically processed 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumo is transferred from e1 to e2 ube2i ubc9 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation 6.0 155.0 1.6236639323887645 0.1786437467168821 0.0 0.0 0.0 0.0 |
| Sumoylation of chromatin organization proteins 4.0 58.0 2.9910808767951624 0.0528261722730647 0.0 0.0 0.0 0.0 |
| Sumoylation of dna damage response and repair proteins 3.0 76.0 1.649515536251253 0.2837526308775903 0.0 0.0 0.0 0.0 |
| Sumoylation of dna methylation proteins 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of dna replication proteins 2.0 46.0 1.822414427677585 0.3101487242993257 0.0 0.0 0.0 0.0 |
| Sumoylation of immune response proteins 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of intracellular receptors 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of rna binding proteins 2.0 47.0 1.781736392262708 0.3191889313297822 0.0 0.0 0.0 0.0 |
| Sumoylation of sumoylation proteins 2.0 35.0 2.4325849589007484 0.2102212619820596 0.0 0.0 0.0 0.0 |
| Sumoylation of transcription cofactors 1.0 41.0 0.9986895161290322 0.63785936798976 0.0 0.0 0.0 0.0 |
| Sumoylation of transcription factors 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of ubiquitinylation proteins 2.0 39.0 2.1687274318853267 0.2464598217650195 0.0 0.0 0.0 0.0 |
| Suppression of apoptosis 1.0 6.0 8.01774193548387 0.1378997973237242 0.0 0.0 0.0 0.0 |
| Suppression of phagosomal maturation 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Surfactant metabolism 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Switching of origins to a post replicative state 1.0 85.0 0.4734543010752688 0.8788100009666788 0.0 0.0 0.0 0.0 |
| Synaptic adhesion like molecules 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Syndecan interactions 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of 12 eicosatetraenoic acid derivatives 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of 15 eicosatetraenoic acid derivatives 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of 16 20 hydroxyeicosatetraenoic acids hete 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of 5 eicosatetraenoic acids 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of active ubiquitin roles of e1 and e2 enzymes 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of bile acids and bile salts 1.0 20.0 2.1069609507640066 0.3904027877902372 0.0 0.0 0.0 0.0 |
| Synthesis of bile acids and bile salts via 24 hydroxycholesterol 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of bile acids and bile salts via 27 hydroxycholesterol 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of bile acids and bile salts via 7alpha hydroxycholesterol 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of diphthamide eef2 1.0 8.0 5.725806451612903 0.1795191310032965 0.0 0.0 0.0 0.0 |
| Synthesis of dna 2.0 117.0 0.6922724872381623 0.7839959020157817 0.0 0.0 0.0 0.0 |
| Synthesis of dolichyl phosphate 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of epoxy eet and dihydroxyeicosatrienoic acids dhet 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of gdp mannose 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of glycosylphosphatidylinositol gpi 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of ip2 ip and ins in the cytosol 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of ip3 and ip4 in the cytosol 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of ketone bodies 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of leukotrienes lt and eoxins ex 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of lipoxins lx 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pa 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pc 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pe 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pg 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pi 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pips at the early endosome membrane 1.0 16.0 2.66989247311828 0.3269170707962712 0.0 0.0 0.0 0.0 |
| Synthesis of pips at the er membrane 1.0 5.0 10.0 0.1163082714273898 0.0 0.0 0.0 0.0 |
| Synthesis of pips at the golgi membrane 1.0 15.0 2.860887096774193 0.3100425591757577 0.0 0.0 0.0 0.0 |
| Synthesis of pips at the late endosome membrane 1.0 10.0 4.452508960573477 0.2191369015278419 0.0 0.0 0.0 0.0 |
| Synthesis of pips at the plasma membrane 1.0 47.0 0.8678997194950911 0.6879878545074485 0.0 0.0 0.0 0.0 |
| Synthesis of prostaglandins pg and thromboxanes tx 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pyrophosphates in the cytosol 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of substrates in n glycan biosythesis 1.0 44.0 0.9287321830457614 0.6638530172648807 0.0 0.0 0.0 0.0 |
| Synthesis of udp n acetyl glucosamine 1.0 8.0 5.725806451612903 0.1795191310032965 0.0 0.0 0.0 0.0 |
| Synthesis of very long chain fatty acyl coas 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of wybutosine at g37 of trna phe 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis secretion and deacylation of ghrelin 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis secretion and inactivation of glucagon like peptide 1 glp 1 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis secretion and inactivation of glucose dependent insulinotropic polypeptide gip 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tak1 activates nfkb by phosphorylation and activation of ikks complex 1.0 25.0 1.6671706989247312 0.4614365431795375 0.0 0.0 0.0 0.0 |
| Tandem pore domain potassium channels 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tbc rabgaps 1.0 39.0 1.0514643463497453 0.6194276439258724 0.0 0.0 0.0 0.0 |
| Tcf dependent signaling in response to wnt 4.0 142.0 1.1604850635906536 0.4583430405426872 0.0 0.0 0.0 0.0 |
| Tcr signaling 2.0 85.0 0.9622945222184284 0.6187485258432601 0.0 0.0 0.0 0.0 |
| Telomere c strand lagging strand synthesis 2.0 37.0 2.293117408906882 0.2282899009392132 0.0 0.0 0.0 0.0 |
| Telomere c strand synthesis initiation 2.0 13.0 7.313949208686051 0.0388074443523606 0.0 0.0 0.0 0.0 |
| Telomere extension by telomerase 1.0 21.0 2.0014112903225807 0.4053192290166058 0.0 0.0 0.0 0.0 |
| Telomere maintenance 4.0 74.0 2.303673469387755 0.1067510978852353 0.0 0.0 0.0 0.0 |
| Terminal pathway of complement 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Termination of o glycan biosynthesis 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Termination of translesion dna synthesis 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tetrahydrobiopterin bh4 synthesis recycling salvage and regulation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tfap2 ap 2 family regulates transcription of cell cycle factors 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tfap2 ap 2 family regulates transcription of growth factors and their receptors 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tfap2a acts as a transcriptional repressor during retinoic acid induced cell differentiation 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tgf beta receptor signaling activates smads 1.0 28.0 1.4814814814814814 0.5000341145668529 0.0 0.0 0.0 0.0 |
| Tgf beta receptor signaling in emt epithelial to mesenchymal transition 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The activation of arylsulfatases 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The canonical retinoid cycle in rods twilight vision 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The citric acid tca cycle and respiratory electron transport 8.0 160.0 2.139113343524787 0.0423793981021662 0.0 0.0 0.0 0.0 |
| The fatty acid cycling model 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The nlrp3 inflammasome 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The phototransduction cascade 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The retinoid cycle in cones daylight vision 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The role of gtse1 in g2 m progression after g2 checkpoint 0.0 67.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The role of nef in hiv 1 replication and disease pathogenesis 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Thrombin signalling through proteinase activated receptors pars 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Thromboxane signalling through tp receptor 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ticam1 dependent activation of irf3 irf7 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ticam1 rip1 mediated ikk complex recruitment 1.0 16.0 2.66989247311828 0.3269170707962712 0.0 0.0 0.0 0.0 |
| Ticam1 traf6 dependent induction of tak1 complex 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tie2 signaling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tight junction interactions 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tlr3 mediated ticam1 dependent programmed cell death 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tnf receptor superfamily tnfsf members mediating non canonical nf kb pathway 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tnf signaling 1.0 39.0 1.0514643463497453 0.6194276439258724 0.0 0.0 0.0 0.0 |
| Tnfr1 induced nfkappab signaling pathway 1.0 28.0 1.4814814814814814 0.5000341145668529 0.0 0.0 0.0 0.0 |
| Tnfr1 induced proapoptotic signaling 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tnfr1 mediated ceramide production 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tnfr2 non canonical nf kb pathway 1.0 58.0 0.6996321448783248 0.7626202729848788 0.0 0.0 0.0 0.0 |
| Tnfs bind their physiological receptors 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Toll like receptor 9 tlr9 cascade 2.0 75.0 1.095224890466419 0.5504015038108375 0.0 0.0 0.0 0.0 |
| Toll like receptor cascades 4.0 103.0 1.6240775097917954 0.2438527884571379 0.0 0.0 0.0 0.0 |
| Toll like receptor tlr1 tlr2 cascade 2.0 70.0 1.176351512264825 0.5131509428836827 0.0 0.0 0.0 0.0 |
| Toxicity of botulinum toxin type d botd 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates metabolic genes 3.0 84.0 1.4853959650707618 0.3374197070778122 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain 1.0 16.0 2.66989247311828 0.3269170707962712 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of caspase activators and caspases 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of cell cycle genes 1.0 43.0 0.9509408602150538 0.6554018259586739 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of cell death genes 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of death receptors and ligands 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of dna repair genes 3.0 61.0 2.0792682926829267 0.1865630132096767 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of genes involved in cytochrome c release 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of genes involved in g1 cell cycle arrest 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of genes involved in g2 cell cycle arrest 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of several additional cell death genes whose specific roles in p53 dependent apoptosis remain uncertain 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Traf3 dependent irf activation pathway 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Traf6 mediated induction of tak1 complex within tlr4 complex 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Traf6 mediated irf7 activation 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Traf6 mediated irf7 activation in tlr7 8 or 9 signaling 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Traf6 mediated nf kb activation 1.0 22.0 1.905913978494624 0.4198721048864768 0.0 0.0 0.0 0.0 |
| Trafficking and processing of endosomal tlr 1.0 8.0 5.725806451612903 0.1795191310032965 0.0 0.0 0.0 0.0 |
| Trafficking of ampa receptors 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trafficking of glur2 containing ampa receptors 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trafficking of myristoylated proteins to the cilium 1.0 4.0 10.0 0.0941782060147337 0.0 0.0 0.0 0.0 |
| Trail signaling 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trans golgi network vesicle budding 0.0 69.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcription coupled nucleotide excision repair tc ner 2.0 82.0 0.9986842105263158 0.5991150617982537 0.0 0.0 0.0 0.0 |
| Transcription of e2f targets under negative control by dream complex 1.0 19.0 2.2242383512544803 0.3751137360333714 0.0 0.0 0.0 0.0 |
| Transcription of e2f targets under negative control by p107 rbl1 and p130 rbl2 in complex with hdac1 1.0 16.0 2.66989247311828 0.3269170707962712 0.0 0.0 0.0 0.0 |
| Transcription of the hiv genome 4.0 67.0 2.561451247165533 0.0808304233724746 0.0 0.0 0.0 0.0 |
| Transcriptional activation of mitochondrial biogenesis 0.0 51.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional activity of smad2 smad3 smad4 heterotrimer 3.0 41.0 3.180038510911425 0.0778634639331788 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by e2f6 4.0 34.0 5.397006802721088 0.0090567827451286 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by mecp2 2.0 45.0 1.8649844647396667 0.3010844649684869 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by runx1 1.0 149.0 0.2669736268526591 0.9755539913579276 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by runx2 0.0 100.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by runx3 1.0 86.0 0.4678368121442125 0.8817945039725321 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by small rnas 3.0 57.0 2.2341915085817523 0.1623088290800169 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by the ap 2 tfap2 family of transcription factors 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by tp53 9.0 333.0 1.113773148148148 0.426379563229989 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by ventx 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation of granulopoiesis 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation of pluripotent stem cells 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation of testis differentiation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation of white adipocyte differentiation 1.0 68.0 0.594607607125662 0.8149044591247521 0.0 0.0 0.0 0.0 |
| Transferrin endocytosis and recycling 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translation 15.0 289.0 2.263007673591616 0.004852437177014 0.0 0.0 0.0 0.0 |
| Translation of replicase and assembly of the replication transcription complex 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translation of sars cov 1 structural proteins 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translation of sars cov 2 structural proteins 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translesion synthesis by polh 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translesion synthesis by polk 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translesion synthesis by y family dna polymerases bypasses lesions on dna template 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translocation of slc2a4 glut4 to the plasma membrane 0.0 66.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transmission across chemical synapses 3.0 139.0 0.8797525107604017 0.6643809433088262 0.0 0.0 0.0 0.0 |
| Transport and synthesis of paps 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of bile salts and organic acids metal ions and amine compounds 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of connexons to the plasma membrane 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of fatty acids 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of inorganic cations anions and amino acids oligopeptides 1.0 44.0 0.9287321830457614 0.6638530172648807 0.0 0.0 0.0 0.0 |
| Transport of mature mrnas derived from intronless transcripts 3.0 43.0 3.0204268292682928 0.0870629174096409 0.0 0.0 0.0 0.0 |
| Transport of mature transcript to cytoplasm 3.0 81.0 1.542995622263915 0.3172642531290227 0.0 0.0 0.0 0.0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of nucleotide sugars 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of organic anions 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of small molecules 1.0 377.0 0.1026402711050103 0.9999251186497418 0.0 0.0 0.0 0.0 |
| Transport of the slbp dependant mature mrna 3.0 36.0 3.663710273466371 0.0569111676931314 0.0 0.0 0.0 0.0 |
| Transport of vitamins nucleosides and related molecules 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport to the golgi and subsequent modification 4.0 148.0 1.111451247165533 0.4903662856580937 0.0 0.0 0.0 0.0 |
| Trif mediated programmed cell death 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Triglyceride biosynthesis 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Triglyceride catabolism 1.0 13.0 3.3383736559139785 0.2750191284248381 0.0 0.0 0.0 0.0 |
| Triglyceride metabolism 1.0 20.0 2.1069609507640066 0.3904027877902372 0.0 0.0 0.0 0.0 |
| Tristetraprolin ttp zfp36 binds and destabilizes mrna 3.0 17.0 8.652439024390244 0.0075942890928168 0.0 0.0 0.0 0.0 |
| Trna aminoacylation 4.0 43.0 4.147776033490319 0.0203336527808929 0.0 0.0 0.0 0.0 |
| Trna modification in the mitochondrion 1.0 9.0 5.009576612903226 0.1995721086637891 0.0 0.0 0.0 0.0 |
| Trna modification in the nucleus and cytosol 1.0 43.0 0.9509408602150538 0.6554018259586739 0.0 0.0 0.0 0.0 |
| Trna processing 7.0 109.0 2.7918894830659537 0.0172365301092223 0.0 0.0 0.0 0.0 |
| Trna processing in the mitochondrion 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trna processing in the nucleus 5.0 60.0 3.685543964232489 0.0153040129106345 0.0 0.0 0.0 0.0 |
| Trp channels 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tryptophan catabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Type i hemidesmosome assembly 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tyrosine catabolism 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tysnd1 cleaves peroxisomal proteins 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ub specific processing proteases 1.0 151.0 0.2633602150537634 0.9767507510369192 0.0 0.0 0.0 0.0 |
| Ubiquinol biosynthesis 2.0 7.0 10.0 0.0115035556388008 0.0 0.0 0.0 0.0 |
| Uch proteinases 0.0 79.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Unblocking of nmda receptors glutamate binding and activation 1.0 9.0 5.009576612903226 0.1995721086637891 0.0 0.0 0.0 0.0 |
| Unfolded protein response upr 4.0 75.0 2.270997413049727 0.1107290245039065 0.0 0.0 0.0 0.0 |
| Unwinding of dna 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Uptake and actions of bacterial toxins 1.0 23.0 1.819098240469208 0.4340702418800846 0.0 0.0 0.0 0.0 |
| Uptake and function of anthrax toxins 1.0 10.0 4.452508960573477 0.2191369015278419 0.0 0.0 0.0 0.0 |
| Uptake and function of diphtheria toxin 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Urea cycle 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vasopressin regulates renal water homeostasis via aquaporins 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vegf ligand receptor interactions 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vegfr2 mediated cell proliferation 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vegfr2 mediated vascular permeability 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vesicle mediated transport 11.0 546.0 0.8130998193669992 0.7864062458494738 0.0 0.0 0.0 0.0 |
| Viral messenger rna synthesis 3.0 44.0 2.946460440214158 0.0918272438847456 0.0 0.0 0.0 0.0 |
| Visual phototransduction 1.0 40.0 1.0244003308519438 0.6287574181217924 0.0 0.0 0.0 0.0 |
| Vitamin b1 thiamin metabolism 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vitamin b2 riboflavin metabolism 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vitamin b5 pantothenate metabolism 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vitamin c ascorbate metabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vitamin d calciferol metabolism 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vldl assembly 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vldl clearance 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vldlr internalisation and degradation 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Voltage gated potassium channels 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vxpx cargo targeting to cilium 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Wax and plasmalogen biosynthesis 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Wnt ligand biogenesis and trafficking 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Wnt mediated activation of dvl 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Wnt5a dependent internalization of fzd2 fzd5 and ror2 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Wnt5a dependent internalization of fzd4 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Xenobiotics 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Yap1 and wwtr1 taz stimulated gene expression 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Zbp1 dai mediated induction of type i ifns 1.0 18.0 2.355313092979128 0.3594428044513148 0.0 0.0 0.0 0.0 |
| Zinc efflux and compartmentalization by the slc30 family 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Zinc influx into cells by the slc39 gene family 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Zinc transporters 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
|
|
